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Influence of surgery on renal amyloidosis. H. Kaaroud, F. Ben Moussa, Post-dysenteric haemolytic uraemic syndrome in children during an
epidemic of shigella dysentery in Kwazulu/Natal. R. Bhimma, N.C.R. Goucha, E. Abderrahim, F. Ben Hamida, T. Ben Abdallah, F. El
Younsi, A. Kheder, H. Ben Miaz, Department and Laboratory of Ne- Rollins, H.M. Coodavia, M. Adhikari, Department of Paediatrics and
Child Health, University of Natal, Durban, South Africa. Post-dysen-phrology, Charles Nicolle Hospital, Tunis, Tunisia. It is well known that
renal amyloidosis (RA) leads to ESRD in a few years. This evolution may teric haemolytic uraemic syndrome (HUS) following E. Coli 0157:H7
infection is the most widely prevalent and best described form of thebe accelerated by several factors such as steroids, renal vein thrombosis,
infections or surgery. We report 22 patients (14M,8F) mean age 5 41.6 disease. However the syndrome following Shigella dysenteriae type 1
(SD) infection has been only sketchily documented. A new epidemicyears (13-72) with RA in whom surgery revealed or aggravated renal
disease. The group I includes 15 patients with no previous history of of SD1 has changed the epidemiology of HUS in Southern Africa. In
this region HUS was endemic but restricted to mainly White childrenrenal disease and who developed oedema few days after surgery with
acute renal failure in 5 of them. Proteinuria was present in all the cases in the northern provinces of South Africa and in Zimbabwe. We report
on 81 of 107 cases of HUS, during the period July 1994 to Februarywith a nephrotic syndrome in 10. Percutaneous kidney biopsy (KB)
showed renal amyloidosis in all patients (AA1 5 8 cases, AA2 5 3 1996, following an outbreak of SD1 dysentery in Kwa Zulu/Natal. All
patients, excluding 1 child, were Black with a mean age of 38 monthscases). Only 9 patients were followed-up (mean period 5 40 months):
2 patients are stationary; 1 is on complete remission 2 are on HD and (range 1–121) and 50 (61.7%) were males. The mean duration of
dysentery was 11.3 days (range 1–41) and that for HUS was 15 days4 died. The group II includes 7 patients with a previous history of
nephropathy (Histologically proven amyloidosis: 3 CRF 5 1, Oedema: (1–91). The majority of patients had acute oliguric renal failure
(90.1%); 42 (51.6%) required peritoneal dialysis. Complications in-3). All these patients developed oedema few days after surgery with
acute RF in 4 patients. KB performed in all of them showed RA (AA1 5 cluded encephalopathy 30 (37.0%); convulsions 12 (14.8%) and hemi-
plegia 2 (2.3%); gastrointestinal-perforation 8 (9%); protein losing33, AA2 5 1). 6 patients were followed up for a mean period of 11
months: 5 died, 1 patient is on HD. The influence of surgery on renal enteropathy 26 (32.1%); toxic megacolon 4 (4.9%); rectal prolapse 5
(6.2%); congestive cardiac failure 3 (3.7%); cardiomyopathy 3 (3.7%);amyloidosis is often unforeseeable. It may have no effect on renal
disease, but very often it reveals RA and sometimes dramatically infective endocarditis 1 (1.2%); septicaemia 15 (18.5%); and dissemin-
ated intravascular coagulation 7 (8.6%). Leukaemoid reactions in 74aggravates the course of the disease with occurrence of irreversible
CRF. The pathogenic role of surgery on RA is discussed. (92.2%) patients; hyponatraemia in 56 (70%) and hypoalbuminaemia
in 67 (87.1%) were characteristic laboratory findings. Stool culture for
SD1 was positive in only 7 (8.6%) patients; shiga toxin assays were
not undertaken. Outcome was as follows: recovery 32 (39.5%); im-Cytoskeletal proteins differentiate between progressors and non prog-
ressors in treated idiopathic membranous nephropathy (IMN). N.A. paired renal function 8 (9.9%), chronic renal failure 26 (32.1%); end
stage renal failure 1 (1.2%) and death 14 (17.3.%). The high mortalityTamimi1,2, P.E. Stevens1, P.L. O’Donnel3, P.G. Strange2, E.C. Mucha-
neta-Kubara4, A.M. El Nahas4, Canterbury Hospitals NHS Trust1, UK. and morbidity in SD1-associated HUS presages the need for the devel-
opment of novel therapy in the management of these patients, whichCytoskeletal proteins such as a-smooth muscle actin (a-SMA) and
vimentin (V) have been associated with renal fibrosis, injury and scar- can be used in developing countries.
ring. This study was aimed at defining the role of these markers in
IMN. We studied 21 patients with IMN treated by immunosuppression
attempting to define the role of a-SMA and V positive cells in this HCV in renal failure.Maher Ramzy, Cairo University, Egypt.Hepatitis C
Associated Glomerulopathy: Glomerulopathy often accompaniesform of nephropathy. There were 15 non-progressors (NP) and 6 prog-
ressors (P). The clinical, histological and immunohistochemical (IHC) chronic liver disease although frequently it is clinically silent (Newell
GC 87). Both cryoglobulinemic and non cryoglobulinemic GN werecharacteristics of both groups were compared. Diastolic pressure was
significantly higher during follow-up period but at presentation in pa- described. Direct evidence for renal deposition of HCV related antigen
has never been presented except recently (Okada K 96). We studiedtients with progressive disease (p 5 0.007). The degree of proteinurina,
severity of interstitial infiltrate and fibrosis did not differentiate P from twenty patients, with HCV chronic liver disease (biopsy proven) and
proteinurial 2gm 24th (data will be presented). Interferon alpha hadNP. However, vascular sclerosis was more severe in P compared to
NP (p 5 0.0053). Glomerular a-SMA was significantly higher in P been tried (Johnson R 94). The optimal treatment strategy, however,
remains to be defined. HCV in chronic patients: Risk factors in dialysis(0.363 6 0.022%) than in NP (0.172 6 0.07%) p 5 0.003. Interstitial
a-SMA was also higher in P but did not reach statistical significance patients: Blood transfusion, nosocomial transmission was minimized
by screening of blood donors and Erythropoietin 1.1. Isolation of HCVwhile interstitial V was higher in P (0.207 6 0.07%) compared to NP
(0.087 6 0.049%) P 5 0.0019. Vimentin was detected in the tubules positive patients in a separate unit is controversial. Following universal
hygiene precautions (CDA-Atlanta) keeps seroconversion very low.as well as interstitial cells. The expression of glomerular a-SMA and
interstitial V may be useful prognostic implications as they appear to Vaccination and Immune serum globulin: Vaccine is unexpected in
the near future due to multiple serotypes. Immune serum globulin hasdifferentiate between patients with IMN who respond to immunosup-
pression and those who continue to progress. not yet proved effective (Marian 1.92). Treatment of chronic HCV in
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dialysis patients: Interferon therapy is the only effective treatment. A anaemia of chronic disorders, including those with malignancy, it is
usual to find raised iron stores and raised serum ferritin concentrations.sustained response of greater than 30% can be achieved (Davis JL
94). HCV in renal transplantation: Incidence: Is mainly determined by This has been mistakenly attributed to some inability of the reticuloen-
dothelial cells to release iron (the R E block). In reality the anaemiathe rate of infection before transplantation (TP), HCV infection can
be transmitted by renal grafts. The rate differs between studies (Roth of chronic disorders is the result of suppression of erythroid activity
as a direct result of the inflammatory cytokines associated with theD 92 Vincenti F 93). Expression and evolution of HCV infection after
renal transplantation: Anti HCV antibodies do not disappear after disease. In consequence the iron that had been circulating in the red
cell pool cannot be reincorporated into new red cells and is depositedrenal transplantation. The biological signs of the disease are in short
term basis (Stempel CA 93: Roth D 94). Immunosuppressive treatment in the iron stores. The serum ferritin concentration reflects the increas-
ing level of these stores: it is raised as a consequence of the anaemia.of renal transplant patient is likely to activate viral replication. It is
possible that Ch liver disease affects the life or renal transplant recipi- Erythropoietin therapy can overcome this erythroid suppression. When
it does, the need for additional iron supply to the erythroid tissue willents at a later stage. The uncertainty does not appear as a contraindica-
tion of transplantation in non-cirrhotic HCV-ve patients (Goffin R 95) be the same as that seen in renal patients. Functional iron deficiency
will supervene when that supply is inadequate. The need for the rapidThere is no effective therapy for Tx recipients with HCV till now.
supply of iron in the correction phase of EPO therapy will be the same
in these patients as it was in those with renal failure. Iron supply will
remain the key to the successful and efficacious use of recombinantDialysis outcomes. Nathan Levin, Renal Research Institute, New York.
It is conventional wisdom that gross and adjusted annual mortality of human erythropoietin in these patients
Americans on dialysis greatly exceeds the analgous rates reported in
many other countries. Many explanations have been offered for the
U.S. findings including higher acceptance rates of older patients with From membrane technology to therapy outcome. G. Brown, J. Vienken,
Fresenius Medical Care, Germany. Membrane manufacturing technol-greater comorbidity; genetic factors; dialyzer reuse with noxious or
ineffective chemicals or resulting in dialyzers with much reduced func- ogy influences the physical and chemical properties of a membrane,
its biostability and the degree of extractables. The chemical propertiestion; under nutrition of patients; failure to deliver an adequate dose
of dialysis in the majority of patients, and less direct physician’s care; depend on the base polymer. But even selection of the same base
polymer can lead to different therapy outcomes due to introductionan alternative explanation is that in some countries the reporting of
mortality and of comorbidity is incomplete. The role of the dialysis of surface modifying groups or as a consequence of copolymerisation
reactions. Established examples are the modified cellulose membranesprocedure itself, including membranes, lines, endotoxins in water and
dialysate, vascular access problems, subclinical infection and chronic Hemophan and the cellulose acetates. Today extensive membrane
development is focussed on modification of synthetic polymers suchinflammation all require elucidation. Evidence of the presence and
importance of increased oxidative stress is controversial. The influence as polysulfone (Psu) which has become established as a highly blood
compatible and efficient membrane for the treatment of ESRD. Investi-of background cardiovascular illness in the general medical community
as affecting dialysis mortality and hospitalization is currently receiving gations of several Psu membranes have uncovered significant differ-
ences in physiocochemical properties and therapy outcome which mayattention. A major question is whether earlier initiation of dialysis
with better management of early cardiovascular damage will make an be related to membrane productin technology and sterilisation influ-
ences. Advanced membrane formation technology additionally offersimpact on the life expectancy of dialysis patients. Increasing attention
is being paid now to measure of quality of life and the effect of psychoso- the manufacturer the possibility to specifically adjust membrane perme-
ability to suit the prescribed therapy. Low-flux membranes can becial factors. Studies of reasons for patients’ choice of modality, dropout
from peritoneal dialysis (particularly), non compliance and decisions more readily manufactured from the polymers already established for
to stop treatment are now underway. The use of quality and outcome renal therapy but limit blood purification potential. Highly permeable
indicators for credentialling and to competitively assess dialysis facili- membranes enable elimination of larger toxins especially when high
ties for managed care has become a major trend in the U.S. fluid fluxes for efficient convective transport across the membrane are
applied. Such membranes impose high requirements on the membrane
manufacturer and on the dialysis centre with regards to such as the
Iron physiology and metabolism in CRF. I. Cavell. University of Wales microbiological quality of water and dialysis fluid.
College of Medicine, Cardiff, UK. Iron metabolism is dominated by
the demand for iron from developing erythroid cells. This is a highly
dynamic process resulting in the release of 2–3 million red cells per Peritoneal dialysis overview. Dr. Ram Gokal, MD, FRCP, Royal In-
second and requires 30 mg iron per day. Of the 4 g of iron in a normal firmary, Manchester, UK. Peritoneal dialysis is now an established form
human, some 3 kg is located within the circulating red cell mass. This of dialytic therapy accounting for about 15% of the global dialysis
is the single biggest store of iron in the body. At the end of each red- population. Its use varies depending on local finances, resources and
cell’s lifespan iron within it will be released and become available for physician biases. Patient survival is equivalent to that on haemodialysis
new red cell synthesis again. A further 1 g of iron will be deposited but technique survival is inferior, whilst long term PD (greater than
in the reticuloendothelial iron stores. This will largely be in the form eight years) is limited to a small fraction of patients starting this therapy.
of haemosiderin. The rate at which the iron within this insoluble mate- The main reasons for this drop out are peritonitis, peritoneal access,
rial can be made available for red cell synthesis can be a limiting factor. inadequate dialysis and patient psychosocial factors. These areas have
The plasma transferrin pool accounts for some 4 g of iron in a normal received considerable attention in the last decade. There have been
subject. The iron in this pool is extremely labile and turns over 10-12 great strides in the understanding of peritoneal physiology, host de-
times a day. The concentration of in this pool is determined by the fence, solute and fluid transport and a means to minimise damage to
transient balance struck between in-flow and out-flow. The first is the the peritoneum (eg newer physiological solutions). There has been a
measurement of iron in the erythroid pool, the second is the measure- decline in peritonitis and access related problems with the use of
ment of iron in the store, the third is an assessment of the adequacy of disconnect systems and better catheters and insertion techniques. Cur-
iron delivery to developing erythoid tissue. Functional iron deficiency is rently there is enormous interest in the adequacy of dialysis and how
a new concept that has emerged from the use of erythropoietin in the targets for these impact on outcomes (survival, hospitalisation
patients with chronic renal failure. It is represents a failure of the rate and nutrition). Patient’s quality of life appears to be better than on
of iron supply to support erythropoiesis. This may occur even when haemodialysis whilst the cost of CAPD in the West is lower than that
there are adequate amounts of iron in the stores. When iron supply of HD). Whilst PD has limitations its use in developing countries is
is adequate each new red cell will contain some 30 pg of haemoglobin. likely in increase. PD has to be integrated with other renal replacement
When iron supply is limiting, cells will emerge with suboptimal amounts therapies for best patient outcome.
of haemoglobin within them. When the individual cell haemoglobin
concentration is 28 g/dl it is deemed to be hypochromic. The percentage
of hypochromic cells in the circulation is a direct measure of the Peritonitis—Pathogenesis, prevention and treatment. Dr. Ram Gokal,
MD, FRCP, Manchester Royal Infirmary, Manchester UK. Peritonitisadequacy of iron supply to the erythroid tissue. In patients with the
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still remains a major cause of treatment failure and hospitalisation in 1 non enteric sepsis). The incidence of chronic renal failure is not less
than 150 per million per year and Immune complex GN are by far thepatients on peritoneal dialysis. It results in a marked increased in
effluent protein loss, and repeated attacks may lead to a hypermeable commonest causes with severe uncontrolled hypertension, the second.
All treatment modalities for ESCRF are available albeit on a verymembrane, loss of ultrafiltration and poorer outcome. Pathogenesis:
Contamination at the time of PD exchanges still remains a major cause, small scale. Besides the costs, maintenance, laboratory and technology
problems mar the implementation programmes. There is no structuralbut about 15-20% of episodes are secondary to catheter infection. Most
of these episodes (70%) are secondary to gram positive organisms. In funding for the care of renal patients and it is done on a fee for service
basis. The subsequent ethical problems are immense. Preventativethe absence of known contamination, peritonitis due to gram negative
organisms is considered to be enteric in origin. Host defense mecha- neprholgy seems to be the only way out as well as horizontal and
vertical co-operation.nisms are important but no direct link has been established with opso-
nins or cellular functions. Prevention: Touch contamination related
episodes (staph epidermidis) have decreased considerably by improve-
ments in connection technology. Prevention by boosting host defence Diabetes and coronary heart disease (CHD): Hypertension, genetics
and microalbuminuria. Estacio R.O., Schrier R.W., University of Colo-and vaccination has not been successful. Careful training, attention to
details, reinforcement and good catheter implantation are important rado Health Sciences Center, Denver, Colorado, USA. Diabetes is re-
sponsible for a significant number of deaths per year with nearly halfstrategies for prevention. Treatment: Initially emperic therapy of peri-
tonitis is with intra peritoneal antibiotics. A recent expert committee of the deaths are secondary to heart disease. Studies have shown that
diabetics are 2–4 times as likely to die from heart disease as peoplereport recommends against Vancomycin as a first line antibiotic (be-
cause of the emergence of Vancomycin resistant enterococci) and who do not have diabetes. The present study in non-insulin dependent
diabetes evaluates various cross sectional baseline patient characteris-advocated first generation Cephlosporins with an aminoglycoside. The
problem area still remain infections with staph aureus, pseudomonas tics from the ongoing Appropriate Blood Pressure Control in Diabetes
(ABCD) Trial and its association with CHD. We evaluated the possibleand fungi where the outcome is poor and catheter removal may be
necessary to impact a cure. associations of glycosylated hemoglobin, insulin use, hypertension (sys-
tolic blood pressure .140 mmHg or diastolic blood .90 mmHg),
urinary albumin excretion and the effect of the angiotensin converting
enzyme (ACE) genotype with CHD. CHD was found not to be associ-Physicochemical aspects of kidney stone disease. A.L. Rodgers, Chem-
istry Department, University of Cape Town. Since urolithiasis involves ated with insulin therapy, glycosylated hemoglobin or the ACE geno-
type but was associated with hypertension (OR 1.39, 95% CI 1.00–1.93),the precipitation of salts from a saturated solution, physiocochemical
principles are applicable. Research focuses on two main areas: stone and overt albuminuria (OR 1.59, 95% CI 1.03–2.46). We also found
that the presence of the DD genotype of the ACE gene was associatedcomposition, structure and ultrastructure and crystallization mecha-
nisms. Two “fingerprint” methods—infrared spectroscopy and x-ray with an increase in left ventricular mass index (parameter estimate
9.90 gm/height (m)2, 95% CI 3.74–16.07). In summary, the presencepowder diffraction—are used for unequivocal identification of stone
composition which is useful for diagnosis and treatment. Application of hypertension and diabetic nephropathy as represented by overt
albuminuria are associated with the presence of CHD. Study alsoof the concept of epitaxy permits the design of molecules which can
block growth sites. Scanning electron microscopy has shown that stone demonstrates an independent association between the presence of the
DD genotype and an increase left ventricular mass which has beenmatric acts as a binding agent in the formation of crystal aggregates. The
metastable limit and crystallization kinetics of a given urine provide a demonstrated to be a predictor of cardiac mortality.
measure of its stone forming potential. Sophisticated experimental
system (eg the continuous crystallizer) distinguish between nucleation,
Peritonitis in continuous ambulatory peritoneal dialysis (CAPD):growth and aggregation mechanisms. Techniques for counting and sizing
Prevalence in a single center. Ben Hamida F., Ben Abdallah T., Abdel-crystals (eg Coulter Counter, Malvern Particle Sizer) have shown that
moula M., El Younsi F., Abderrahim E., Goucha R., Ben Moussa F.,aggregation is probably the crucial step that needs to be targeted by
Ben Maiz H., Department of Nephrology and Internal Medicine (Pr H.potential inhibitors. Urinalysis data have been used to develop power-
Ben Maiz) Charles Nicolle Hospital. Tunis-Tunisia. Despite technicalful mathematical expressions which provide quantitative estimates of
improvements of peritoneal dialysis over the last ten years, peritonitisthe risk of stone formation. These include physiocochemical risk ratios,
remains the major complication and the most common cause of tech-quotients and indices (eg relative supersaturation, activity products)
nique failure and patient morbidity. We report our experience in pa-which are useful for assessing the efficacy of therapeutic regimens.
tients with CAPD peritonitis. It is a retrospective study including 145
peritonitis occuring in 69 patients (31 males and 38 females) between
January 1991 and February 1997. 74% of patients were autonomousEthics & economics of treatment of renal failure in Africa (Sudan).
Suleiman, S.M. Sudan is a million sq. miles in central Africa over the and 26% were helped by a member of their family when they manipu-
lated the catheter. During the period of study, 88.4% of patients pre-Equator, having borders with 9 African countries and a 10th border on
the Red Sea. Population about 36 million. Transport, communications, sented 1 to 3 peritonitis and 11.6% presented 4 to 7 peritonitis, with
an average of 2.1 peritonitis per patient. The mean delay betweensocio-economic conditions are rather poor over most parts with high
prevelance of most endemic diseases known to affect the kidneys. peritonitis and the begining of treatment by CAPD was 15.5 months
(1 to 188 months). Organisms isolated in peritoneal fluid were: 50Facilities for dialysis: 3 PD & 4 HD (governmental centres) and 2
private centres in Khartoum Port Sudan (over the Red Sea). Incidence (34.5%) cocci gram positive, 28 (19.3%) bacilli gram negative and 3
(2.1%) bacilli gram positive. Organism culture was negative in 61of ARF pmp (unknown), CRF pmp (estimated 70–140). Aetiology of
ARF: Dehydration (GE) in children, in adults: P.falciparum malaria, (42.1%) of cases. There are no difference between this bacteriological
spectrum and the one observed in a previous study realized fromhair-dye poisoning, septicaemia (septic abortions) and snake bites.
CRF: commonest causes G/N (idiopathic and secondary) Renal stones 6 1986 to 1990. All patients received medical treatment: intraperitoneal,
intravenous or oral antibiotics. The outcome was favourable in mostinfections uncontrolled DM, BP. Emergency PD is done on available
beds. Selection for chronic dialysis, young with a suitable donor with cases. In conclusion, CAPD peritonitis were frequent, occured mainly
after an aseptic manipulation of the catheter. Antibiotics initiated priora possibility for Tx, ARF has got priorities. Funding is mainly govern-
mental with help from national societies (2) alms from some persons to isolating the organism must be active against staphylococcus and
bacilli gram negative.donations & help from individuals and societies in other countries.
Renal failure in Africa. Youmbissi T. Joseph: Cameroon. The region An evaluation of the Banff Classification. W.D. Bates, D.R. Davies,
K. Welsh, D.R. Gray, S. Fuggle, P.J. Morris, Oxford Transplant Cen-of Central Africa has a population of about 50 million people and
presents a great diversity in its geography and economy. There is no tre—Tygerberg Hospital—Stellenbosch University. This study was done
on 383 consecutive transplants performed between 1985 and 1989, 351reliable data concerning the incidence and prevalence of Acute Renal
Failure but in Cameroon, medical causes predominate (Enteric disease with graft followup to 5 years. Regarding diagnostic value, use was
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made of a previous study of a subgroup of this cohort in 1987–1988. Peritoneal dialysis in the treatment of acute renal failure: A Congolese
experience. Assounga A.G., Mpio I., Assambo-Kieli C., Ngakosso N.,A pre Banff sensitivity for the diagnosis of acute rejection of 75%
(24/32) was derived with a specificity of 87% (88/101). With Banff Brazzaville’s University Hospital and Marien Ngouabi University, Braz-
zaville, Congo. Management of acute renal failure is still posing majorclassification the sensitivity and specificity were both marginally
lower—73% (16/22) and 85% (79/93). Of note was the large borderline problems in Africa. Peritoneal dialysis, a renal replacement therapy
relatively easy to introduce, can be very useful. This is a report of agroup—48/181 (27%) of the suitable biopsies. Concerning prognostic
value, the most severe biopsy in the first 35 days was correlated with retrospective study of the use of peritoneal dialysis in the treatment
of acute renal failure in Brazzaville’s University Hospital from Januarygraft outcome at 3 months, 1, 3 and 5 years. Biopsies were available
on 293 of the 351 patients (83%). Groups as follows: Normal or non- 1990 through September 1996. Records of patients hospitalized for
ARF (192 cases) were examined and all patients treated with peritonealrejection—60/293 (20%); Borderline—(34%); AR I—(18%); AR
IIA—(6%); AR IIB—(14%); AR III—(1%); AR IIIC—Necrotising dialysis (18 cases 5 0.9%) were included. Peritoneal dialysis was the
only replacement therapy available. All patients with ARF needingvasculitis—(3%); Widespread necrosis (? AR III)—(3%). Regarding
outcome the last 2 groups had a very poor prognosis—18% at 3 months, dialysis were put on peritoneal dialysis, except those having a recent
abdominal surgery. The continuous ambulatory peritoneal dialysis6% at 5 years. The other vascular rejection groups, IIB and III, had
an intermediate outcome—78% at 3 months, 61% at 5 years. An (CAPD) method was applied using a rigid catheter in 12 cases and a
Tenckhoff catheter in 6 cases. A lactate containing dialysis solutioninteresting finding was that the other 4 groups (normal, borderline,
and cellular AR I and AR IIA) had not only the predictably best was used. A complete recovery of kidney function was observed in 11
cases, chronic renal failure in 4 patients and death in 3 cases. Thusoutcome—95% at 3 months but that at 5 years all 4 had almost identical
graft survival of 78%. Conclusions: Banff has diagnostic value with peritoneal dialysis, easy to use, may help save lives in many centers,
and especially in those where hemodialysis is not available.moderate sensitivity and specificity but the large borderline group is
one unresolved area. Prognostically 3 groups emerge—severe necrotis-
ing vasculitis or widespread necrosis leads to very frequent early loss,
other vascular involvement leads to moderate early loss, with slower Renal transplantation in the management of end stage diabetic ne-
phropathy. V.K. Rao, University of Minnesota Medical School, Minne-loss out to 5 years while the normal, borderline and usually reversible
forms of cellular rejection show steady decline over 5 years with similar apolis. Diabetic patients now comprise 30% to 40% of dialysis and
transplant population in the United States. There is no ideal test that5 year outcome. These 3 groups are very similar to the NIH-CCTT 3
types of acute rejection. will predict the future risk of developing diabetes in the renal donor. We
use the rapidity and magnitude of Beta Cell insulin release following an
intravenous glucose load to screen the family donors. All potential
candidates undergo dobutamine stress echo cardiography and DopplerPatient function and well-being on CAPD. A.Z. Muranda, S. Naicher,
L. Botden, G. Nel, Addington Hospital and University of Natal, Durban, assessment of peripheral vasculature and carotid arteries. Occlusive
vascular disease continues to progress in these patients leading to muchSouth Africa.Dialysis outcomes underemphasise function and well-being,
while the nutritional and mortality benefits are well established. Aim: of the morbidity and mortality in the post transplant period. Compared
to non diabetics, diabetic transplant patients have higher incidence ofto assess the effect of adequate dialysis on patient well-being. Method:
coronary and peripheral vascular disease. Approximately 17% undergoadequate dialysis was defined as an ‘Adequest’ urea clearance, KT/V .
amputations for ischemic disease. Retinopathy and neuropathy remain2.1. Well-being was assessed by a structured questionnaire with graded
stable in the majority of transplanted patients. Infection risk appearsresponses. Results: 82 patients were eligible, all functionally anephric.
to be high, compared to the non diabetics but the rejection rate is
similar. Cardiovascular events account for the majority of deaths, par-KT/V,2.1 KT/V 2.1
ticularly in the second decade after renal transplantation. Of the differ-(n 5 55) (n 5 27)
ent risk variables, recipient age, donor source, cyclosporine immuno-
Age years 39.7 40.6 suppression, type II diabetes and pre-existing clinical vascular disease
CAPD months 46 31 have an independent effect on survival results. The risk of graft loss
Hb/g/dL 8.5 8.8 from chronic and acute rejection is similar to the non diabetic patients.
Diabetic vascular lesions are frequently observed in the transplanted
kidneys but the incidence of graft loss from recurrent disease is lessIn the underdialysed group, the odds ratio for loss of gainful employ-
ment was 1.5, nausea 7.3, vomiting 9, asthenia 4.4, unsatisfactory sex than 5%. It is gratifying to note that 60% of diabetic renal transplant
patients can attain full rehabilitation; 30% partial rehabilitation and1.4, insomnia 1.2, restless legs, 0.2 and poor coping 1.8. Conclusion:
Adequate dialysis improves patient function and well-being. This fo- only 10% are medically disabled.
cusses rehabilitation at outcome types that are important to patients
and families’ activities of daily living.
Hypertension in Africa: Its impact on the kidney. O.O. Akinkugbe,
University of Ibadan, Nigeria. Hypertension is today, indisputably, the
most common cardiovascular condition, and indeed the most endemicAcute peritoneal dialysis in children. R.D. Gilbert, Red Cross War
Memorial Children’s Hospital, Private Bag Rondebosch 7701, W Cape. non-communicable disorder on the African continent. Its prevalence
in both rural and urban communities varies from 5 to 15 per cent ofFifty-two children underwent acute peritoneal dialysis (PD) between
April 1995 and March 1996. Their ages ranged from 2 days to 14 years. the adult population, and the risk factors associated with its genesis
are much the same as in Western societies. The kidney is both a primeThe causes of renal failure were: acute tubular necrosis (ATN) 35,
haemolytic-uraemic syndrome 7, tumour lysis syndrome 5 and miscella- cause and a vulnerable target. Renal complications occur in a significant
percentage of young adults with severe hypertension. However a sub-neous 5. The causes of ATN were diarrhoea 7, sepsis 19, post cardiac
surgery 3 and cardiac abnormalities without surgery 4 and toxins 2. stantial proportion of African hypertensives will already have had one
form or other of glomerulonephritis, and in such cases hypertensionTwenty-five patients were initially dialysed using acute “stick” type
catheters, 15 using catheters inserted using a guide wire and 12 with accelerates the unrelenting progression to renal failure. The nephrotic
syndrome is a common pathway and its aetiologic profile in AfricaTenckhoff catheters, 6 were of which were placed using a peel-away
sheath technique. Twelve catheters required revision. The overall mor- differs in some respects from that in Western Communities. Many
hypertensive renal failures seen for the first time often present withtality was 52%. Mortality was higher in those dialysed in intensive
care units (75%) than in the renal ward (0%, p , 0.02), reflecting end-stage shrunken kidneys, at which point it becomes impossible to
unravel the pathogenesis—hypertension or glomerulonephritis, a “henmultiple organ system involvement in these patients. Six of seven
children under a month died. This was not significantly different from or egg” dilemma. The role of bacterial and protozoal nephropathy
(Malaria, Schistosomiasis) will be briefly discussed. Programmes arethose over 1 month. PD can be performed on almost any child. The
mortality rate in children with renal failure and multiple organ system now being put in place in a number of African countries to address the
emerging non-communicable disease (NCD) before their devastatingfailure is extremely high. ATN secondary to sepsis and diarhoea is the
most frequent cause of ATN requiring dialysis in our hospital. effects take centre stage. The recent Nigerian experience on NCD
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survey and strategies for control will be presented. The prohibitive blood mononuclear cells to predominant IgA response and specific
glomerular susceptibility. It appears that schistosomal glomerulopathycost of renal replacement care in the African context dictates that
preventive strategies be given greater prominence in our efforts to satisfies the pre-requisites for the induction of progressive glomerular
pathology, by providing a “switching” mechanism as well as “priming”confront the challenge of hypertensive renal disease in Africa.
the glomeruli for subsequent IgA deposits by prior deposition of im-
mune complexes involving parasitic antigens.
Hypertension: Recent advances. Omar Abboud, University of Khar-
toum, Sudan. Angiotensin (AT) II is produced in plasma by the sequen-
tial processing of circulating angiotensinogen by renin and AT I con- Management of renal failure in central Africa in 1997. Assounga A.G.,
Brazzaville’s University Hospital and Marien Ngouabi University, Braz-verting enzyme (ACE). The enzyme renin, produced by the kidney,
is the major regulating factor of AT II production in blood. Local AT zaville, Congo. Sub-saharian Africa is lagging in the development of
nephrology in Africa. In this report, we examine the current status ofII production has also been described in several tissues where the
conversion from AT I to AT II is done by local enzyme independent the management of kidney failure in the region. This is based on a
review of publications on nephrology in the region. The central Africaof the control of ACE. The role of this tissue angiotensin system is being
more appreciated recently. Its possible inhibitors will be discussed region includes: Angola, Burundi, CAR, Congo, Democratic Republic
of Congo, Gabon, Rwanda and Tchad. With the population of almostincluding the new group of AT II receptor blockers. Further develop-
ments in the renin angiotensin system (RAS) are the recognition of one hundred people, and between 30 and 40 patients reaching the end
stage of kidney failure per million, per year, the region has less thanangiotensin 1-7 which has a vasodilator effect antagonistic to the action
of AT II. Also with the recent ability of cDNA cloning of ACE, it 20 trained nephrologists practicing in 6 nephrology centers. Renal
conservative treatment is offered in all centers. Renal replacementwas possible to study the ACE gene. A frequent insertion/deletion
polymorphism characterized by the presence of a 287 bp fragment therapy is available in 3 countries: Hemodialysis is used in 2 centers
while peritoneal dialysis is practiced only in 2 centers. No kidneysituated in the intron 16 of the ACE gene. It could have a predictive
value on the therapeutic effect of ACE inhibitors on proteinuria. On transplantation is currently practiced in the region, but patients trans-
planted abroad are currently following their immunosuppressive treat-the treatment aspect microalbuminuria is now considered as important
in hypertension as it is in diabetes in detecting early renal damage. It ment in the region. Obviously, a lot needs to be done both in nephrology
training and equipment, in order to advance the level of basic carecan play a role in the initiation of hypotensive therapy in borderline
cases with no other evidence of target organ damage. The target level of kidney failure in Central Africa. Strengthening the few existing
nephrology centers and creating new ones may be the way to go.of blood pressure control to be achieved by hypotensive therapy will
be dicussed with its implications of the reduction of the incidence of
CVAs and ischaemic cardiac events. Nitric oxide is emerging as an
attractive therapeutic agent for hypertension being recognized as the Renal failure in Africa. Anthony J.O. Were, Nairobi, Kenya. This report
looks at Renal diseases in Sub-Saharan Africa with particular emphasismediator for many vasodilator substances. A focus on its actions and
therapeutic potential will be made. on the pattern of renal diseases in East Africa. The causes of acute
renal failure range widely from acute glomerulonephritis due to acute
post Streptococcal Glomerulonephritis to the fluid losses in cholera.
Haemorrhage in Obstetrics, in Schistosomal and Portal Hypertension,IgA Nephropathies. Rashad S. Barsoum, Cairo University. Egypt. IgA
nephropathy (IgAN) is the commonest form of glomerulonephritis and in massive road traffic accidents are highlighted as important causes
of acute renal failure. Malaria associated renal failure is a frequently(GN) worldwide, albeit being quite rare in Africa and other areas.
Primary IgAN may be encountered as an isolated mesangioprolifera- recognised cause to which clinician in the region must be alert. An
tive GN (Berger’s disease), associated with cutaneous vasculitis and approach to management in a District hospital setting is suggested.
arthritis (Henoch Schonlein syndrome—HSS), or it may overlap with The grave implication of development of chronic renal failure and
other renal disorders as minimal change disease, membranous nephrop- end stage renal disease, principally from chronic glomerulonephritis
athy, Wegener’s granulomatosis or Thin Basement Membrane disease. is presented against the scarce availability of renal replacement therapy
Males are more susceptible, with a peak age of onset around the in the region.
twenties, except with HSS, which starts one decade earlier. Hematuria
is the predominant symptom, being gross, painless and intermittent in
one third of cases. In another third, it is microscopic and often associ- Renal failure in the southern zone of Afran. C.R. Swanepoel, Depart-
ated with persistent proteinuria. The remaining third of patients pres- ment of Medicine, Renal Unit, Groote Schuur Hospital. The southern
ent with hypertension, chronic renal failure, acute nephritic syndrome, zone of AFRAN includes Mozambique, Malawi, Zambia, Angola,
or acute renal failure. The main laboratory features include the charac- Zimbabwe, Botswana, Namibia, Lesotho, Swaziland, Madagascar and
teristic urinary findings, elevated serum IgA in 35–50% of cases and South Africa. The 1995 AFRAN Directory of Nephrology mentions
the presence of circulating IgA immune complexes, rheumatoid factor only 4 of these in relation to nephrolgists and dialysis /transplantation
and/or fibronectin aggregates. Urinary IL-6 is increased, correlating centres. The zone is beset with poor finances and, as a consequence
with disease activity. Renal biopsy shows focal or diffuse mesangial cell of civil uprising and struggling economics the practise of “high tech”
proliferation, widening of the mesangial matrix and variable crescent medicine is limited. Direct contact with the embassies in attempting to
formation, which is the main criterion for histological classification define the details of dialysis facilities was unhelpful. A medline search
into 6 grades. Immunofluorescence characteristically shows polymeric of published material from this zone was also undertaken. It is clear
IgA1 mesangial & capillary loop deposits, together with IgG, IgM, C3 that the strength of Nephrology lies in the south. There are more publica-
and other complement components of the properdin pathway. EM tions, on matters Nephrology and more dialysis units with support trans-
shows the mesangial & subendothelial deposits. the course of primary plantation than anywhere else in the zone. In addition the private sector
IgAN is fairly benign, with a renal survival of 80% at 10 years and has built up a strong presence. This has arisen partly as a consequence
70% at 20 years after the onset. There is no specific treatment, but of budgetery restrictions imposed by the department of health. The
response to steroids is usual in minimal change disease with IgA depos- ability to easily communicate with other nephrologists outside of South
its, common with HSS and reported with crescentic IgAN. Some benefit Africa is exceedingly difficult. If AFRAN is to play any role in facilitat-
has been obtained with ACE-inhibitors, fish oil and intravenous IgG. ing better “renal treatment” then channels of reliable communication
Secondary IgAN is reported with chronic liver disease, celiac disease, must be established so that we can speak to each other in Africa. If
dermatitis herpetidiformis, several seronegative rheumatoid diseases, not then AFRAN will become an organization with no future.
familial Mediterranean fever, hematological malignancies, AIDS and
many other conditions. In most of these conditions, the disease is mild
or asymptomatic. A notable exception is hepatosplenic schistosomiasis, The role of leukocytes in glomerular injury. Adu D., Dept. of Nephrol-
ogy, The Queen Elizabeth Hospital, Birmingham. A key feature ofwhere IgA glomerular deposits hallmark a severe and progressive
disease. The pathogenesis of IgAN is complex. Suggested mechanisms antibody mediated glomerulonephritis is the intra-glomerular accumu-
lation of leukocytes. This is seen in post-infectious glomerulonephritisinclude abnormal IgA or its circulating forms, switching of peripheral
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and also in auto-immune glomerulonephritis such as anti-GBM disease, race (socio-economic status, physiologic differences, severity of hyper-
tension), BP control (adequate control of BP and type of antihyperten-lupus and vasculitis. The migration of leukocytes from the lumen of
blood vessels is dependent on a series of activation steps that include sive therapy), and possibly other factors like genetics. The lack of
reduction in ESRD may be that currently accepted standards for BProlling, adhesion, diapedesis and migration. The first step is dependent
on selectins (P-Selectin and E-Selectin) on endothelium and enables control are not adequate and that different antihypertensive agents
affect glomerular haemodynamics in different ways. These factors needthe leukocytes to sample chemoattractants (chemokines) bound to
proteoglycans on the endothelial cells. Chemokines lead to activation an indepth analysis to improve the important public health issue of
increasing morbidity and mortality from ESRD.and upregulation of leukocyte integrin receptors which bind adhesion
molecules ICAM-1 and VCAM-1 on endothelium. Subsequently leu-
kocytes migrate across the endothelium up a chemoattractant gradient.
On in vitro human glomerular organ culture, glomerular endothelium Acute renal failure: New perspectives on pathophysiology, prevention
and treatment. Charles L. Edelstein and Robert W. Schrier, Departmentcan be induced by cytokines to express E-Selection and VCAM-1 and
to increase the expression of ICAM-1. In the renal biopsies of patients of Medicine, University of Colorado School of Medicine, Denver, Colo-
rado, USA. Acute renal failure (ARF) is a very common renal diseasewith active glomerulonephritis there is an increase in glomerular endo-
thelial expression of ICAM-1 and new expression of VCAM-1. In vitro affecting about 5% of all hospitalized patients. ARF still carries a very
high mortality of more than 50% and there has been no significantstudies show that these adhesion molecules are able to bind human
leukocytes. Recent studies show that there is an increased expression change in mortality over the last four decades. In the last decade several
new and important pathophysiological mechanisms that underlie theof chemokines in the glomeruli of patients with a glomerulonephritis.
These chemokines which include MCP-1, MIP-a/b, RANTES and IL-8 renal dysfunction have been discovered. These pathophysiological
mechanisms include the role of 1) both calcium and calcium-dependentattract different subsets of leukocytes and thereby confer specificity
to leukocyte recruitment. Once within glomeruli, activated leukocytes enzymes like calpain, 2) nitric oxide, 3) oxidant stress, 4) loss of polarity
of the tubular cell, 5) tubular obstruction and arginine-glycine-asparticrelease reactive oxygen products and proteases which lead to tissue
injury and in addition produce cytokines including IL-1 and IL-8 which acid (RGD) peptides, 6) neutrophils, 7) intercellular adhesion mole-
cules (ICAM), 8) vascular factors e.g. loss of renal blood flow autoregu-in themselves augment further leukocyte recruitment and activation.
A clear understanding of the mechanism of leukocyte recruitment into lation, 9) atrial natriuretic peptide and 10) growth factors. A better
understanding of tubular and vascular mechanisms has led to therapeuticglomeruli will lead to the development of novel therapies.
studies in animals and clinical trials in humans. For example, the systemic
administration of cyclic RGD peptides in the rat ameliorates ischemic
ARF by preventing tubular obstruction. Also, in vivo targeting of induc-Lupus nephritis (LN). Nctkong, Department of Medicine, National Uni-
versity of Malaysia, Kuala Lumpur. Renal involvement occurs in about ible nitric oxide synthase with antisense oligodeoxynucleotides protects
the rat kidney against ischemia. In human studies, the use of biocompati-50–80% of patients with SLE. Immunopathogenetic studies are now
focussed on dysregulation of apoptosis which may lead to quantitative ble dialysis membranes enhances recovery of renal function and patient
survival in ARF. In this lecture, the pathophysiology of ARF will beor qualitative changes in the release of nucleosomes which may be
the major autoantigen rather than the poorly immunogenic dsDNA. correlated with the rationale for both current and future therapies.
Nucleosome antibodies coupled with nucleosomes are demonstrated
to have a high affinity for the GBM resulting in LN. LN presents in
many ways and variable histological patterns or combinations thereof Anaemia of chronic renal disease and pathogenesis and management,
with reference to the use of erythropoietin and intravenous iron. Na-(WHO classification) are found on renal biopsy. The histopathologic
class of LN is highly correlated with prognosis and an aggressive thera- than W. Levin, Renal Research Institute, New York The investigation
of the anemia of chronic renal failure has hardly changed for manypeutic approach to severe LN has resulted in a markedly improved
renal survival. The goals of treatment of severe active LN encompasses years. However, the availability now of Epoetin and intravenous iron
has transformed the management of anemia with consequent well-remission induction, remission consolidation and remission mainte-
nance in the short term PLUS prevention of progressive renal failure documented evidence of physical and psychosocial benefit. Current
issues for debate include the methods for prescribing Epoetin, leveland minimization of drug toxicity in the long term. To this end, low
dose steroid-cytotoxic combinations are superior to high dose steroids of the target hematocrit (hemoglobin), whether oral iron is needed
(in hemodialysis), how to assess iron status, concerns about the ratealone. IV cyclophosphamide is now widely employed although optimal
dosing and duration of therapy remain controversial. Azathioprine of administration of IV iron and safe levels for body iron, and the
comparison of the relative efficacy of subcutaneous versus intravenousmay be preferable for chronic therapy. Plasmapheresis is a useful adjunct
for refractory disease. The role of other therapeutic modalities such as iron. The concept of functional iron deficiency requires that intrave-
nous iron be given in substanially larger amounts and therefore to acyclosporine A, methotrexate, IV immunoglobulins, FK506, lefluomide
and total lymphoid irradiation remain to be defined. However, pros- higher level of transferrin saturation and of ferritin. The risk of this
approach is still under investigation with the role of reactive ironpects for specific immunotherapies are novel and promising and include
monoclonal antibodies, soluble receptors and receptor ligand blockers species in promoting oxidative damage being of particular interest.
The benefits are controversial. The use of EPO in hospitalized patientsamongst others. Ultimately, perhaps gene replacement therapy.
with infective or posttraumatic problems is not clarified. The interim
somewhat negative results of the “Normalization of Hematocrit Study”
Why has improvement in hypertension treatment not reduced the in dialysis patients with heart failure (as opposed to other patients)
incidence of end-stage renal disease? Yackoob K. Seedat, Department require satisfactory explanation. The improvement in survival in ESRD
of Medicine, University of Natal, Durban, South Africa. Hypertension patients in whom the hematocrit reaches to 32-36 is well documented.
is an important cause of End-Stage Renal Disease (ESRD) in the USA Cardiovascular correlates are of interest. The just issued (U.S.) Na-
and in Sub-Saharan Africa. Antihypertensive therapy has led to a tional Kidney Foundation-Dialysis Outcomes Quality Initiative Prac-
substantial decrease in incidence of stroke (42%) and to a lesser extent tice Guideline on anemia deal with most of the above topics with
of myocardial infarction (16%), yet there has been an increase in supporting evidence and rationales.
hypertension related (ESRD). In 1991, about 190,000 persons in the
USA either underwent dialysis or received a transplant for ESRD.
Hypertension was found to be the underlying cause in 29% of these Economy in renal health care in Africa. Aziz El Matri, Faculty of
Medicine, Tunis. Of the hundred of thousands of people in the worldpatients, second only to diabetes mellitus (36%). Both in the USA
and South Africa hypertension was found to be the most common with end stage renal disease (ESRD) about 75% live in the developing
world and about 12% in Africa. In Africa, the average Gross Nationalcause of ESRD, but it is not clear whether this is related to the higher
incidence and severity of hypertension in blacks. Moreover BP control Product (GNP) per capita is US $600, i.e. 7 times lower than the
average GNP. Twenty two out of 53 countries have a GNP per capitain black patients does not necessarily lead to improved renal function.
These findings suggest that factors other than BP elevation participate lower than 400 US $ and are classified among the 40 poorest countries
in the world. Some countries have even a negative economic growth.in the progression of nephroclerosis. They include misdiagnosis, black
Abstracts 2123
It is proven that there is usually a correlation between the yearly per plantation: Started at Mansoura in 1983. The actual number is un-
known, probably six/M (360/y). Results of rental transplantation arecapita expenditure in a country and the level of health care. In the
continent, and mainly in sub-saharian Africa, there are many endemic comparable to international standards. Most donors are live unrelated.
A law for cadaveric donation is still absent. Strict rules are now appliedinfectious and parasitic diseases and health indicators are generally
poor as for example the ratio of doctors/10000 population is ranging to control the Egyptian kidney market. Funding: Eighty percent of
chronic dialysis pts. are sponsored by Ministry of public health.between 0.9 and 1.5 and yearly expenditures per capita for health care
is ranging between 9 and 28 US $. As for renal diseases, they are
particularly common and are associated with very high morbidity and
mortality. Acute renal failure remains fairly common. Its incidence, Nephrology in Tunisia. Ben Abdallah T., Kheder A., Ben Moussa F.,
El Younsi F., Abderrahim E., Ben Hamida F., Goucha R., El Matrithough not precisely defined is ranging between 100 and 150 per million
population per year. The reported incidence of ESRD ranges between A., Ben Maiz H, Service de Nephrologie et de Medecine interne (Pr.
Ben Maiz H.) Charles Nicolle University Hospital. Tunis—Tunisia.89 and 192 per million population. Haemodialysis is available for man-
agement of acute renal failure in most of the major hospitals of the Nephrologic care has been available in Tunisia since 1962 but it has
developed particularly since 1968 when a comprehensive hemodialysiscapital cities. The number of patients treated by regular dialysis in
Africa cannot be precisely defined owing to the scarcity of reliable programme was set up in Charles Nicolle Hospital in Tunis. Renal
Biopsy has been performed since 1967. Until December 1996, 4492registries. On the other hand availability of dialysis services in certain
countries does not reflect the accessibility. Renal transplantation is biopsies have been done. An intermittent peritoneal dialysis pro-
gramme has been active since 1982 and has been completed by CAPDperformed mainly in North Africa, South Africa, Zimbabwe and Ke-
nya. So the countries of sub-saharian Africa represent what is un- in 1983. Renal transplantation has been performed abroad since 1971
but a national programme was started in June 1986. Today Nephrologicdoubtly the worst cases and medical staff and decision makers should
act together to improve it. In Africa where the population is 670 million care including hemodialysis and renal transplantation is available in
Tunisia at 4 University Hospitals for adults and one nephrologic pediat-and where the incidence of ESRD is at least 100 per million population,
there would be a prevalent population of some 250 000 patients after ric unit in Tunis. Until December 1996 there are 72 Hemodialysis
centers (15 Public and 57 private). With 2849 patients (313 pMp with5 years. If the cost of haemodialysis for 1 patient for 1 year is US
$12000 as reported by North African studies (in USA US $25000 to a progression in 1996 of 32.5 pMp): 2796 were treated by hemodialysis,
43 by CAPD and 9 by IPD. About 210 renal transplantation (RT)30,000), the total expenditure for haemodialysis would be US $2000
million per year. It is high when you know that in certain countries were performed in Tunisia among them 171 in Charles Nicolle Hospital.
Distribution of main renal diseases are: glomerulonephritis 20.4%,the cost of keeping one patient alive on dialysis exceeds the average
GNP generated by 10 citizens. But it is necessary to set up national pyelonehritis 13%, vascular disease 17.5%, diabetic nephropathy 11.8%,
hereditary nephropathy 6.4% and unkown 30.9%. Plasmapherisis hasprogrammes of treatment of ESRD. It may be that the changes in
political climate we are witnessing now will lead to a situation where been available at Charles Nicolle Hospital since 1983. The incidence
of acute renal failure (ARF) in Tunisia is about 15 pMp: 120 casesreduction in domestic and political turmoil will allow these nations to
effectively address domestic social and health problems. So Nephrology per year. The main aetiologies of ARF are: Functional ARF 22 to
47%, Acute tubular necrosis 13 to 37%, among them 17% were obstet-and mainly ESRD must have a place in the hierarchy of health priorities
and it would be reasonable to divert funds to their treatments. National- rical and 68% toxic, Urological ARF 10%, Acute glomerulonephritis
19% and Vascular ARF 1%. Expenses of renal replacement therapyization of the issues of nephrologic diseases and renal failure manage-
ment should be a pressing target of doctors in Africa. It cannot be are on the charge of Minestry of Health or social security funds. Hemo-
dialysis costs about US Dollars 18,000, CAPD 15,000/patient/year andover emphasized that very little indeed can be achieved, unless opinion
leaders, decision makers, fund raising organizations and public infor- RT 19,000 the first year. The Tunisian Society of Nephrology was created
in November 1983. It organizes 2 to 3 scientific meetings per year.mation media are recruited into the same boat. According to the
African tradition of solidarity the healthy majority of the people should
support the sick minority.
Clinical course and management of viral hepatitis in renal transplant
recipients. Venkateswara K. Rao, MD, Professor of Medicine, Univer-
sity of Minnesota Medical School, Minneapolis, MN. ApproximatelyRenal disease/failure in Egypt. Maher F. Ramzy, M.D.—F.A.C.P, Pro-
fessor of Medicine & Director of Nephrology Centre—Cairo University. 15% of renal transplant recipients develop chronic hepatic dysfunction.
Infection with hepatitis B and C viruses is the predominant cause ofRenal disease/failure: The exact incidence of renal failure is unknown.
Analysis of health certificates showed that 192/M die with renal failure chronic liver disease. Because of the immunosuppressed state, intra
hepatic viral replication continues to occur which leads to post necroticevery year. (Barsoum et al, 74) Acute renal failure: The incidence
seems to be decreasing. Major surgery is associated with high risk of cirrhosis and hepatic failure over a period of 10 to 15 years. Hepatic
failure with or without super imposed sepsis is the leading cause ofA.R.F. Cresentic G.N. (Panci-immune) seems to be increasing. Drugs,
hydrocarbons and other environmental factors has to be considered. death in renal transplant recipients surviving into the second decade.
These patients remain asymptomatic despite ongoing histological pro-Chronic renal disease/failure: Despite the lack of registry, a lot of data
point to increasing of H.T.N. renal disease, diabetic nephropathy and gression. Liver enzymes are only modestly elevated and fluctuating
levels from normal to abnormal are quite common. There is no correla-chronic interstitial nephritis. The latter probably accounts for most
cases of ESRD of unknown aetiology. This could be related to enviro- tion between level of hepatic enzymes and histologic severity of liver
disease. Initial morphology has a predictive value in terms of subse-mental pollution, industrial toxins and drug misuse. In the dialysis
pool, the percentage of diabetics is increasing from 5.2% to 8.4% (El quent histological and clinical progression and patient mortality. Older
age, female sex and morphologic diagnosis of chronic active hepatitisSharkawy, 93). One in four Egyptian is or will become H.T.N. (Ibrahim
M, 95) this points to possible magnitude of related renal disease. In are associated with progression to cirrhosis in the post transplant pe-
riod. Hepatitis B patients have significantly more severe morphologicadults the predominant pattern of primary G.N. is mesangiocapillary
G.N. (Ramzy et al, 90); however G.N. as cause of ESRD dropped forms of liver disease and have higher incidence of death from hepatic
failure compared to those with hepatitis C. With improved surveillancefrom 30.4% to 20.2% (El Sharkawy M, 96). HCV and other infections
are major causative factors. In nephrotic children, increased incidence measures and pre transplant vaccination, the incidence of hepatitis B
has declined steadily in the United States. A third of renal transplantof focal segmental sclerosis (up to 25%) is observed (Sohh et al, 90).
Treatment modalities: Dialysis: One hundred and thirty four dialysis patients now have hepatitis C infection, of which another 1/3 develop
clinical disease. It is our policy to obtain a liver biopsy in HCV infectedunits are recognized, a lot are not registered yet. The pool of patients
on chronic dialysis is continuously expanding during the last three patients if they have clinical disease or have high viral RNA titer.
Those with histologic evidence of chronic active hepatitis are treateddecades; it is about 245/M of general population (Ministry of Health
data, 1996). Most pts. are on ch. HDx, few on intermittent PD and with alpha interferon. Contraindications are mental depression, neutro-
penia, frequent acute rejections, significant hepatic fibrosis or cirrhosisoccasional cases are treated by C.A.P.D. The majority of pt. are inade-
quately dialyzed; the 1st year mortality on dialysis is .50%, the annual in the biopsy and clinical hepatic failure. Biochemical and histologic
improvement was observed in several of our patients who were treatedmortality thereafter is about 35% (El Saeed et al, 95). Renal Trans-
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with interferon. The patients, however, need close follow up to monitor lar to those with HBMN and the other histological types. This report
delineates the natural history of HBV infection in black South Africanthe side effects, particularly, renal function. Most patients require long
term therapy to control the disease, provided they are able to tolerate children with membranous nephropathy, although other histological
patterns may also be seen.the medication. Every effort should be made to prevent the infection
by screening the blood and organs for HCV along with other standard
surveillance measures during the pre and post transplant period.
Acquired hair and skin fairness in hemodialisis patients. M. Ben Hmida,
N. Abbes, K. Kammoun, S. Bouacida, K. Charfeddine, H. Turki,
J. Hachicha, P. Reygagne, D. Rabier, A. Zahaf, A. Jarraya, Dpts. ofStrategies for the treatment of glomerulonephritis. Adu D., Dept. of
Nephrology, The Queen Elizabeth Hospital, Birmingham. Our current Nephrology—Dermatology. CHU—He´di Chaker—3029 Sfax. With re-
cent advances in medicine, uremic patients are living longer with antreatment of glomerulonephritis is based on the concept that most of
these disorders are immune mediated. Our lack of understanding of improving quality of life. Several skin diseases have been reported in
patients with chronic renal failure, and the opportunity has been of-the precise mechanisms leading to this immune activation means that
our therapies are based on overall suppression of the immune system. fered to elucidate newer cutaneous abnormalities among patients un-
dergoing long-term hemodialysis. Hyperpigmentation was the mostNevertheless current treatment strategies are associated with improved
survival and reduced drug toxicity. This is likely in part to be due prevalent cutaneous abnormality observed in these patients, but hypo-
pigmentation remains an exceptional event. We report here a seriesto better treatment of the consequences of glomerulonephritis e.g.,
hypertension and hyperlipidaemia. In some types of infection associ- of 6 maintenance hemodialysis patients (5 M 1 1 F) with an acquired
hair and skin fairness. Mean age was 42 years (range 23–56). Meanated glomerulonephritis, e.g. that due to endocarditis and Hepatitis C
eradication of the infection (and hence of antigen) leads to resolution duration of hemodialysis therapy was 52 months (range 10–96). The
determination of the hair aminoacid composition was carried out. Aof the glomerulonephritis. This strategy is not effective in glomerulone-
phritis due to malaria and schistsomiasis probably because these infec- polarized light micrograph and scanning electron micrography of head
hair were performed. This clinical feature seems to be similar to thetions trigger an autoimmune response which is then responsible for
the glomerulonephritis. Steroids and Cyclophosphamide are effective ‘dilution’ of hair color observed in phenylketonuria. A low plasma
tyrosine level with normal plasma phenylalanine concentration corrob-in inducing remission in minimal change nephropathy and to a lesser
extent in FSGS. Here there is evidence of a circulating proteinuria orates this diagnosis in these cases. This apparent resemblance would
suggest an acquired impairment of phenylalanine hydroxylase activityinducing factor, possibly produced by lymphocytes. Of interest these
disorders recur after transplantation and remission can be induced by in uremic and hemodialyis patients. The mechanism of this impairment
will be discussed.plasma exchange which removes the circulating factor. In the classical
autoimmune disorders anti-GBM nephritis and lupus nephritis, there
is the glomerular deposition/assembly of antibodies and complement.
There is clear evidence that steroids and Cyclophosphamide are effec- Congestive heart failure in elderly hemodialysis patients. Pedro Lea˜o
Neves, Idale´cio Bernardo, Centros de Dia´lise de Faro e Portima˜o. FMC.tive in treatment. By contrast in idiopathic membranous nephropathy
and MCGN in which there are also glomerular immune deposits, ste- Algarve. Portugal. Cardiovascular disease is the main cause of death in
chronic hemodialysis patients (CHD). Congestive heart failure (CHF)roids and immunosuppressants are either ineffective or of dubious
efficacy. Their reasons for this are not clear. In Wegener’s granulomato- either preceding or appearing after the initiation of CHD is also associ-
ated with increased mortality. In this study, carried out in the centressis and microscopic polyarteritis antibodies directed against neutrophil
cytoplamsic activate neutrophils and may thereby lead to glomerular of Faro and Portima˜o, we included all patients aged over 65 y (N 5
67, f 5 33, m 5 34, mean age 5 72.6 y, mean time on CHD 5 51.3injury. Here treatment with Cyclophosphamide and steroids are effec-
tive in inducing remission of both the glomerulonephritis and vasculitis. months). We looked for the presence of CHF after the initiation of
CHD and we divided the population in two groups: patients with CHFWe need to develop treatment strategies that focus on the likeihood
that the drugs needed to induce remission may be different from those (G–I 5 15) and without CHF (G–II 5 52). We compared both groups
respecting several biological, laboratorial and echocardiographic pa-needed to consolidate remission and to prevent relapse. This is already
possible when there is a good immunological marker, e.g anti-GBM rameters. There were no differences between groups respecting age,
sex distribution, time of hypertension preceding CHD, time on CHD,antibodies and ANCA that correlated with disease activity.
blood pressure levels, interdialytic weight gain and for the presence
of ischaemic heart disease. The body mass index (BMI) (19.8 vs 21.9,
Hepatitis B virus-associated nephropathy in black South African chil- p 5 0.066) and the plasma creatinine level (8.1 vs 9.4 mg/dl, p 5 0.018)
dren. Bhimma R., Coovadia H.M., Adhikari M., Department of Paediat- were lower in G–I. The other laboratorial parameters analysed were
rics and Child Health, University of Natal, Durban, South Africa. Hepa- not different between the groups. The G–I showed a higher left ventric-
titis B virus (HBV) is the prime cause of membranous nephrotic ular mass index (LVMI) (209 vs 147 g/m2, p 5 0.001) and a lower
syndrome (NS) in South African children but the spectrum of glomeru- fractional shortening (30.2 vs 38.6%, p 5 0.001). The left ventricular
lar injury has not been adequately documented in black children. One diastolic diameter (LVDD) was higher in G–I (5.5 vs 4.91 cm, p 5
hundred and thirty three children with NS in whom HBV infection 0.001), but both the left ventricular posterior wall and the interventricu-
was detected are included in this study. In 70 patients the histological lar septum thickness were similar. In conclusion, the results showed
type was membranous (HBMN); of whom 46 were followed up for a that our elderly hemodialysis patients with CHF have: 1—lower BMI
mean of 3.4 years (range 1–11). Spontaneous elimination of both HbsAg as well as lower creatinine levels (probably with the same meaning)
and HbeAg occurred in 10 (22%) patients while 16 (35%) cleared 2—lower fractional shortening and a higher LVMI due to an increased
HbeAg alone. Co-existing liver disease occurred in 3 (4.3%) and hypo- LVDD.
complementaemia (C3, C4) in 47.1 and 11.4% of children respectively.
65 (92.9%) patients had normal renal function; 1 (1.4%) impaired
renal function; 3 (4.3%) chronic renal insufficiency and 1 (1.4%) end Soluble interleukin-2 receptors in renal failure and early post-trans-
plantation. Mohamed Hani Hafez and Inas Raafat, Departments ofstage renal disease at last hospital visit. 12 of these patients were in
remission and all had become free of HbeAg. HBMN was clinically Nephrology & Clinical Pathology, Cairo University. Soluble Interleu-
kin-2 receptors (sIL-2R) released during T-lymphocyte activation wereindistinguishable from 24 children with idiopathic membranous ne-
phropathy (IMN) although serum triglycerides, complement compo- Quantified by ELISA. Forty subjects were included and divided into
control, acute rejection, stable transplant, hemodialysis and uremicnents (C3, C4, Factor B) and serum globlulins (alpha 1, alpha 2, beta)
were different. There were 23 patients with histological lesions other conservation groups. In 16 renal failure patients mean sIL-2R was
significantly higher than controls, with higher values reported withthan HBMN, of whom 6 (26%) had diffuse mesangial proliferation, 5
(22%) focal segmental glomerulosclerosis, 5 (22%) membranoprolifer- hemodialysis (p , 0.05). This could be caused by non-dialyzable nature
of sIL-2R molecule and altered IL-2 dependent pathway. There wasative glomerulonephritis, 4 (17%) focal mesangial proliferation and 3
(13%) had intermediate changes (unclassified). Forty patients were no significant difference between those treated with erythropoietin
and others. SIL-2R did not correlate with hemoglobin but correlatedunbiopsied and had clinical, biochemical and serological findings simi-
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positively with serum creatinine. Transplanted patients were evaluated Renal function and sodium handling in patients with portal vein throm-
bosis compared to normal controls. Rayner B.L., Voigt M., Robson S.,to exclude cyclosporin toxicity, acute tubular necrosis or concomitant
Kirsch R., Renal Unit and MRC Liver Research Centre, University ofinfection. Among transplantation cases, eight showed criteria of acute
Cape Town. Patients with cirrhosis of the liver have impaired abilityrejection and eight had stable graft function. Pre- then post-transplanta-
to excrete salt and water, and may also be prone to develop renaltion samples were taken within two weeks after surgery. Pre-operative
failure due to the hepatorenal syndrome. The precise mechanismsMHC and sIL-2R, intraoperative ischemia time were not significantly
behind this are largely unknown but porto-systemic shunting may bedifferent and therefore did not predict allograft loss. Patients with
an important contributing mechanism. Our aim was to study renalstable graft, when compared to their initial levels showed significant
function and sodium handling in patients with portal vein thrombosisdrop of sIL-2R after transplantation (p , 0.001), following pattern of
without liver disease (PVT) compared to normal controls to determineserum creatinine concentration (r 5 0.54, p , 0.05). In patients with
the role (if any) of porto-systemic shunting. Nine patients with provengraft rejection, significant rise in sIL-2R (p , 0.02) was obtained in
PVT and 9 sex and age matched controls were studied. All underwentcomparison to their pre-transplant values. Serum sIL-2R and creatinine
standard measurements of GFR and renal blood flow using inulin andincreased with positive correlation (r* 5 0.46, p , 0.1). Serum sIL-
PAH acid clearances, and sodium excretion, before, during and after2R is elevated at diagnosis of uremic syndrome and remains so during
an intravenous saline challenge. Renin and aldosterone levels werehemodialysis treatment. It is only after successful renal transplantation also measured before and after. At baseline there was no differencethat levels decrease, thus it is an additional non-invasive test diagnosing in inulin clearance, PAH clearance, fractional excretion of sodium,
acute rejection. SIL-2R follow-up could have more implications with renin or aldosterone. During and after the saline infusion there was a
the use of anti-CD25 in clinical transplantation. drop in the PAH clearance and a concomitant increase in the fractional
excretion of sodium. Aldosterone and renin levels fell after the infusion.
There was no difference between the PVT and control groups. In
Long term follow-up of kidney donors. S. Naicker, M. Kirsten, A. conclusion renal function and sodium handling was very similar be-
Sookoo, I. Holmes, A. Muranda, A.A. Haffejee Renal Unit, Addington tween controls and patients with PVT. It is, therefore, unlikely that
Hospital and Depts. of Medicine and Surgery, University of Natal, portosystemic plays a significant role in the genesis of the hepatorenal
Durban, South Africa. There is a worldwide shortage of organ donors. syndrome or the impaired ability to excrete sodium in patients with
The problem is more pronounced in our province of Kwa Zulu/Natal liver cirrhosis.
where the rate of cadaver organ donation is very low and therefore
both patients and nephrology staff are under pressure to seek living
Urinary tissue Kallikrein excretion in severe hypertension of preg-donors. We studied 135 living donors who underwent nephrectomy in
nancy: Decrease and correlation with uric acid and renal impairment.a 10 year period: 85 females and 50 males; 78 (57.8%) were of Indian
S.M. Khedun, T. Naicker, J. Moodley, S. Naidoo, K.D. Bhoola, Depart-origin, 33 (24.4%) Black, 15 (11.1%) White and 9 (6.7%) of mixed
ment of Pharmacology EM Unit and MRC Pregnancy Hypertensionrace groups. The majority of donors (57%) were siblings, while 14.8%
Research Unit, Natal Medical School, Durban. The aim of this studywere parents, 6.7% children, 17.8% spousal and 3.7% were cousins.
was to establish whether urinary tissue kallikrein (uTK) excretionThe mean age of the donors was 34.2 years (range 21–56 years). Donors
was increased in severe hypertension of pregnancy and if these levelswere hospitalised for a mean of 6.1 days (range 3–15). Post-operative
correlated with other laboratory markers of severity of this complica-complications noted were left lower lobe atelectasis and chest infection tion. Random untimed urine samples were collected at 28 weeks ofin 11.1%, other infection in 5.2%, pneumothorax in 2.2%, ileus in 2 gestation and near at the time of delivery from all patients; 66 had
pts, depression in 1 pt and prolonged pain at the site of surgery in severe hypertension of pregnancy and 66 were normotensive pregnant
11.1%. Increase in proteinuria was noted in 3 pts (0.4 grams daily in women. Urine specimens were analyzed for uTK using a chromogenic
one pt at 9 years and 0.26 grams and 0.66 grams in 2 pts at 2 years). Blood substrate S2266. uTK levels were decreased in severe hypertension in
pressure recordings were virtually unchanged from pre-nephrectomy pregnancy compared with normotensive pregnant women (1.55 6 0.95
levels. This study suggests that unilateral nephrectomy in normal indi- vs 3.02 6 2.5 ng TK/mg protein; p , 0.0001). uTK excretion correlated
viduals is associated with few major adverse effects and living donor positively with uric acid (r 5 0.72; p , 0.0001) and serum creatinine
kidney transplantation is a viable option. levels (r 5 0.84; p , 0.0001). There was a significant difference in uTK
excretion between 28 weeks of gestation and at near delivery in the
severe group (1.94 6 0.65 vs 1.21 6 0.25 ng TK/mg protein; p ,
0.0001). This study shows that uTK excretion is decreased in severeThe 4th decade of renal transplantation: Where have we come?
hypertension of pregnancy and correlates closely with uric acid andWhither are we going? L.P. Margolius & J.R. Botha, University of
serum creatinine the measure of renal function.Witwatersrand, South Africa. Since the advent of renal transplantation
on 21st August 1966, 1786 renal transplants have been performed in
1483 patients at Johannesburg Hospital in South Africa. During this
Plasma vasoactive peptides in renal disorders. P. Gathiram, S. Naicker,period 1222 patients have received primary cadaver grafts, 303 patients
A. Nadar, J. Duursma, Dept. of Physiology, University of Durban-West-subsequent grafts and 249 patients related living donor grafts. 12 pa-
ville. The mechanism of occurrence of hypertension in renal disorderstients have received unrelated living donor grafts (from spouse or close
is postulated to be multifactorial, including salt and water retention,friend). The aim of this paper is to report the results of the various imbalance between vasoconstrictor and vasodilator substances. In thisgroups, to elucidate on some points and to attempt to explain discrepan- study the role of plasma endothelin-1 (ET-1), atrial natriuretic pep-
cies between our results and the literature. tide (ANP) and renin-angiotensin system (renin activity) was assessed
in haemodialysis (HD), continuous ambulatory peritoneal dialysis
1 year 5 years 10 years 15 years 20 years (CAPD), and renal transplant (TP) patients and compared with normalActuarial
controls. Plasma ET-1 was measured using an EIA kit (Wako Chemi-survival Pt Gr Pt Gr Pt Gr Pt Gr Pt Gr cals) and ANP using an RIA kit (Peninsula Lab.) after extraction of
the samples using Sep-Pak C18 cartridges and renin activity by RIAAll patients 83 61 73 47 58 32 47 22 34 14
(Biodata). Compared to controls there was a significant elevation inRLD 92 78 89 67 79 48 71 36
plasma ET-1 (0.004) in all groups while plasma ANP (p , 0.006) andCD1 all 82 59 69 44 53 29 40 20 30 20
renin activity (p , 0.05) were significantly elevated in both dialysisCD2 all 82 52 77 41 60 27 55 19
groups.CD1 CYA 85 63 71 46 53 32
CD1 no CYA 76 53 64 40 51 26
CD1 black 84 58 70 37 36 17 ET-1 ANP Renin
CD1 white 92 78 91 69 81 51 Group (pg/ml ) (pg/ml ) (ng/ml /h)
Abbreviations are: Pt, patient; Gr, graft. HD 3.3161.39 87.2645.8 6.4267.5
CAPD 2.9660.95 54.4617.6 6.0165.8Optimal patient and graft survival appears to depend on close HLA
TP 3.160.32 33.8612.3 3.4262.18matching, optimal crossmatch techniques use of Cyclosporine based
Control 1.5760.13 24.362.91 1.4260.86therapies and short ischaemic time.
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A positive correlation was found between plasma ET-1 levels and in 4 cases, a new ureteral bladder implantation in 3 cases and one
patient had a simple suture of a limited pyelic fistula. All patients hadANP in CAPD (r 5 0.7) and HD (r 5 0.89) patients. Our results
support the clinical observation that the largest changes in volume and their fistulas closed, 7 patients had no alteration of renal function but
only one patient had altered his renal function. The patients treatedblood pressure occur in dialysis patients with concomitant changes in
pressor substances. percutaneously had nephrostomy and double J ureteral stent. One pa-
tient had a total recovery, one patient had ureteral stenosis which was
successfully managed surgically and the last dead with sepsis. More than
50% of ureteral fistulas are due to ureteral necrosis. We insiste on theInsulin-like Growth Factor-1 (IGF-1) and uraemic cardiomyopathy.
E.C. Muchaneta-Kubara, T.S. Johnson, A.M. El Nahas, Sheffield Kidney importance of preserving ureteral vascularisation. During renal harvest-
ing. Surgical management for ureteral fistulas provides the best results.Institute, Northern General Hospital Trust, Sheffield, UK. The mortality
of patients with end stage renal failure is related to the severity of left
ventricular hypertrophy (LVH). Since IGF-I has been put forward as
a myocardial growth factor, we have studied the changes in myocardial Acquired cystic kidney disease in hemodialysis patients. Hachim K.,
Benghanem Gharbi M., Fatihi E., Zahiri K, Ramdani B., Zaı¨d D, ServiceIGF-1 during the course of experimental uraemia in subtotally nephrec-
tomized (SNx) rats. Controls included sham-operated Wistars and de ne´phrologie, CHU Ibn Rochd, Casablanca, Morroco. This study
carried out over 62 patients undergoing long term dialysis. We havespontaneously hypertensive rats (SHR). Animals (n 5 6) were sacrificed
on days 7, 30, 90, and 120 after SNx. Extractable (eIGF-1) and immuno- discovered an incident of acquired cystic kidney disease reaching 33%.
Sex influence has been evident: 61.9% among men and 38.09% amongstainable (iIGF-I) myocardial IGF-I were determined by radioimmuno-
assay and immunohistochemistry respectively. IGF-I gene expression women have this pathology. Also, hemodialysis period has an influence
on its emergence. It comes in average to 85 6 47 months to patientswas studied by Northern blot analysis of IGF-I mRNA. Uraemic cardio-
megaly was due primarily to hypertrophy as shown by a significant with acquired cystic kidney disease, against 49.5 6 37.5 to patients
without. According to age and causes of renal failure in dialysis patients,increase in myocardium protein content (71.7 6 14 mg/heart) compared
with sham (39.2 6 5 mg/heart) p , 0.001. Histologically, perivascular they have no influence. Most of our patients are anuric (57.1%) and
badly purified. They are asymptomatique in 33.33% of the cases, pres-and inter-myocytic fibrosis was detectable from day 90 onward. A
biphasic increase in myocardial eIGF-I was noted with an early peak enting flanc pain in 57.1%, hematuric in 6.5%, and urinary infection
in 19.04%. The hematocrit ratio depends mainly on cystic proliferationon day 7: 235 6 32.9 ng/heart, compared to sham (128.6 6 14.6ng/
heart) p , 0.001 and another peak on days 90-120, with no changes and not on the presence of the cyst. That ratio is about 22 6 7 in
Grade 1 patients according to Goldsmith Scale; in the same way thedetected in SHRs. The iIGF-I was raised in uraemic myocytes through-
out the study. A positive correlation was noted between eIGF-I and Grade 3 patients have the ratio in 29.6 6 6.3. The cystic haemorrhage
has been the only complication, observed in 4.7% of the cases. RenalIGF-I mRNA (r 5 0.551) p , 0.01. Progressive uraemic cardiomyopathy
is associated with elevated myocardial IGF-I content and expression. cancer has never been detected in any patient.
Chronic hemodialysis for children first Moroccan experience. FatihiDiagnosis of active CMV infection in renal transplant recipients by
CMV antigenaemia. Z. Noveljic, A.A. Walele, E.J. van Rensburg and E., Benghanem G.M., Hachim K., Zahiri K., Ramdani B., Zaid D.,
Service de ne´phrologie-he´modialyse CHU Ibn Rochd, Casablanca, Mo-M.R. Moosa, Dept. of Virology and Medicine, University of Stellen-
bosch, Cape. Active CMV infection in an important complication early rocco. In this study, we report the experience of the nephrology-hemo-
dialysis unit in UHC Ibn Rochd in Casablanca about the infant hemodi-post-transplantation. It is difficult to diagnose as current diagnostic
methods have major drawbacks. The aim of the study was to establish alysis through 40 cases taken in charge from 1994 to the end of 1996.
The mean age of the children has been 10 years old, with age bracketsa diagnostic value of the CMV antigenemia (CMV Ag) assay. During
the period July 1996 and April 1997 all new renal transplant recipients from 3 to 16 years old. The sex-ratio was 2/3. The predominant cause
of nephropathy has been the classical glomerulonephritis (70%) thenwere monitored for active CMV infection during the first four months
post-transplantation. Weekly sampling of whole blood peripheral leu- the chronical interstitial nephropathy (25%). The arteriovenous fistula
constitutes the totality of the permanent vascular approach. No onekocytes was assessed for CMV by conventional virus culture, detection
of early antigen in rapid culture (shell vial culture) and direct detection was under peritoneal dialysis ambulatory (CPDA). The mean statural
delay in 82% of the children is 22 DS. The cardiovascular complica-of the CMV lower matrix antigen pp65 (CMV Ag). A positive CMV
Ag was defined as .10 per 50000 WBC. Active CMV infection was tions dominated of the high blood pressure (40%), the pericarditis
(17.5%), the cardiac failure (16%). 62.5% are protected against thedefined as CMV Ag . 30 per 50000 WBC or a positive virus culture.
Clinical manifestations were retrospectively correlated with the labora- viral hepatitis B (VHB), 10% suffer from viral hepatitis C positif
(VHC1). The kidney transplantation has been achieved in three chil-tory findings. Thirteen consecutive renal transplant patients were stud-
ied. CMV Ag was positive in eleven (85%). CMV Ag . 30 per 50000 dren. The rate of mortality in the hemodialyzed patients has been 20%.
WBC was detected in four patients with two confirmed on conventional
virus cultures. CMV was clinically suspected in three of them. CMV
Pregnancy in chronic hemodialysis outcome of multicentric womenAg 10–29 per 50000 WBC was detected in seven patients and all were
study. H. Bahloul, K. Kammoun, K. Charfeddine, M. Ben Hmida, J.negative on conventional virus cultures. CMV was clinically suspected
Hachicha, Department of nephrology. He´di Chaker Hospital Sfax.—in three of them. The detection of CMV by rapid culture was negative in
Tunisia. Pregnancy is an infrequent event in hemodialysis women.all the patients. Expressed quantitatively CMV Ag could discriminate
Spontaneous abortion is frequent. It is exceptionnel to have viablebetween CMV infection and CMV disease. A high CMV Ag result
baby. Our objectifs are to precise the frequency of pregnancy in womensuggestive of CMV disease was confirmed by conventional viral cultures.
on hemodialysis and the complications in both mother and foetus. A
preliminary questionnaire was sent to fifteen among nineteen dialysis
units in south of Tunisia. The questionnaire asked for the number inUrinary leakage post renal transplantation. M. Jemni*, M. Hajri*, S.
Karray*, S. Friaaa*, M. Chebil*, T.B. Abdalah**, H.B. Maiz**, M. all patients treated in the unit. The number of women of child bearing
age (18 to 44 years) and those used contraception methods. When aAyed*, *Department of Urology; **Department of Nephrology, Hoˆpital
Charles Nicolle, Tunis. From 1986 to 1996, 160 patients underwent pregnancy was reported, a more detailed questionnaire was sent to
determine the senority of dialysis, residuel fonction (kidney); bloodkidney transplantation. 95% of transplantations were from a relative
alive donor. We had 11 ureteral fistulas (6.8%). Fistula incidence in pressure control and the final outcome of these pregnancies. All units
responded to the first questionnaire (100%). These units cared for 695Leadbetter-Politano was 5.8% and 8.1% in Lich-Gregoir reimplanta-
tion (p 5 0.8). 8 patients were treated surgically and 3 by percutaneous dialysis patients. 297 was the number of all women and 94 presented
those of child bearing age (18 to 44 years), and only 14% of those wereprocedure. Intra-operative findings consisted in an extended necrosis
of the ureter in 4 cases, distal ureteral, necrosis in 1 case, uretero- used contraception methods. Twelve (12) pregnancies were reported in
eleven women (11); occurred during the survey period (Jan 1990 tovesical leakage in 2 cases and a limited pyelic fistula in 1 case. Surgical
procedure consisted in pyelo-ureteral anastomosis with native ureter Dec 1996). The frequency was 15%. The incidence of pregnancy in
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our study was 5%. The foetus complications were observed in 83%. Meyers, Metabolic Stone Clinic, University of the Witwatersrand. Renal
stones are rare in the South African black population , 1%. Previously,Successful ended pregnancy necessite to have some precautions: inten-
sified hemodialysis, controlled the blood pressure, the correction of the cause and composition of urinary stones in black and white South
Africans differed, but are becoming increasingly similar. The aim ofanemia, to have hemoglobin .7.5 g/dl by transfusion or erythropoietin.
Since, mother and foetus’s complication are frequent and dangerous, this study was to compare lithogenic risk factors in normal black men
(BC, n 5 12) and male black (BSF, n 5 18) and white (WSF, n 5 101)contraception must be used for dialysed women at child bearing age. The
best contraception method for these patients is microprogestative pill. recurrent stone formers. Patients with cystinuria, MSK and hyperpara-
thyroidism were excluded. Standard metabolic workup, comprising 2 3
24 hr urines, fasting serum and urinary ca:creatinine, was followed.
There were no differences in serum Ca, Ca11, PTH, and phosphateCystine: A risk factor in the precipitation of calcium oxalate calculi.
Martins M.C., Meyers A.M., Whalley N.A., Dept. of Medicine, Nephrol- and urinary Na and Ox between the groups. Serum urate urinary(u)
ogy, University of the Witwatersrand and Metabolic Stone Clinic, Johan- Ca, creatinine, phosphate and urate gave values WSF . BSF . BC.
nesburg, South Africa. We noted that a number of patients who pro- Urinary cirtrate was lowest in BSF , BC , WSF. Urinary volumes
duced calcium oxalate (CaOx) calculi also had cystine (Cy) in their were higher in the SFs. The various categories of risk factors as found
stones. 50% of these also had urinary Cy excretions resembling those in the two groups (B:W) of SFs were as follows: Nil metabolic change
found in heterozygous carriers but 50% did not. We also documented 11%:9%, increased uCa due to increased uNa 11%:18%, renal hyper-
that urinary Cy levels (mg/24 hr) in normal black controls (n 5 24) calciuria 6%:10%, absorptive hypercalciuria 6%:7%, dietary hyper-
were significantly lower (44.4 6 21.4) than in whites (n 5 24) (71.2 6 oxaluria 17%:19%, mild metabolic hyperoxaluria 11%:21%, hypocitra-
37.6); p , 0.03. Considering that less than 0.5% of the black population turia 72%:58% and low volume in 17%:14%. Hypocitraturia only was
form recurrent calculi as opposed to 7% of whites, the question of the found in 44% of BSF and 25% of WSF. Calculi available for analysis:
role of Cy in CaOx precipitation. 24 hr urine samples were collected BSFs had only CaOx whereas the WSFs had 82% CaOx, 16% CaPhos,
in 9 normal controls and stored at 48C. 3 specimens were collected and 2% uric acid. Although certain risk factors were similar, hyperoxa-
at a time, pooled, spun and filtered (SFU) and ultrafiltered (UFC). luria, dietary hypercalciuria, and renal hypercalciuria were more fre-
Metastable limit (MSL) of urine was determined. Inhibitory activity quent in whites. Urinary hypocitraturia is the single most common
was measured in UFU and SFU using 3 different concentrations of cause in both groups. As urbanisation occurs, the urine of BSFs is
Cy. A Coulter Multisizer II was used to measure particle number, becoming more like that of WSFs. Predictably nephrolithiasis will
diameter and volume. Results were confirmed via the incorporation become more common in the black population.
of 14C-oxalate into the crystals. Scanning Electron Microscopy was
used to further demonstrate the agglomerates. Cy caused both growth
and aggregation of CaOx crystals, in a dose dependent manner. MSL Predictive factors of chronic renal failure in systemic lupus erythemato-
of urine did not change with increasing doses of Cy, indicating that sus. Kammoun K., Hentati A., Bahloul H., Ben Hmida M., Charfeddine
epitaxy is unlikely to be the mechanism involved in Cy induced CaOx K., Bahloul Z., Jlidi R., Jarraya A., Hachicha J., Department of Ne´phrol-
precipitation. In conclusion, Cy results in marked enhancement of ogy. CHU—He´di Chaker—3029 Sfax. Renal involvement in lupus is
CaOx precipitation and this plus the epidemiological evidence of low frequent. It remains the major cause of morbidity and mortality in
urinary Cy levels in a non-stone forming population (SA blacks) to- lupus erythmatous, despite immunosuppressive therapy. For precising
gether with the finding of Cy in CaOx stones in the non-cystinuric the predictive criteria of outcome to chronic renal failure we reviewed
population, point to the possibility that urinary Cy may be a major all our cases of lupus. During the period 1985–1996 we observed 107
risk factor in the formation of CaOx calculi. cases of lupus. All patients fulfilled four of the 11 American Rheuma-
tism Association (ARA). 51 patients developed a lupus nephritis con-
firmed by renal biopsy. They were divided into two groups GI: patients
Arterial hypotension in chronic hemodialysed patients. Kheder A., El with evolution to chronic renal failure GII: patients who until this
Matri A., Menjour A., Ben Hamida F., Abderrahim E., Ben Abdallah T., report have a normal renal function. The were no difference among
Ben Moussa F., Ben Maiz H., Department of Nephrology and Internal the two groups with regard to age, Sex, renal (edemia, proteinuria,
Medicine. (Pr H. Ben Maiz) Charles Nicolle Hospital, Tunis-Tunisia. hematuria) and extra renal symptoms. But hypertention and initial
Arterial hypotension can occurs in chronic hemodialysed patients renal failure (Blood creatinine $ 150 mmol/l) cryoglobulinemia and
(CHD). In order to study (i) the frequency of hypotension in patients diffuse proliferative lupus nephritis were more observed in group I.
on maintenance hemodialysis and (ii) the role of sympathetic nervous Treatment including pulse cyclophosphamide and Corticosteroids were
activity in blood pressure regulation in uremic patients, we studied in more effective than steroids alone.34 CHD (17 normotensives—NT—and 17 hypotensives—HOT), the
duration of dialysis treatment, response to the valsalva maneuver
(VM), plasma noradrenaline levels (NA), plasma renine activity (PRA) Intensive pulse therapy for focal segmental glomerulosclerosis in Southand plasma aldosterone concentration (PAC). NT and HOT were
African children. Adhikari M., Bhimma R., and Coovadia H.M., De-matched with regard to age and duration of dialysis (mean age 39.8 6
partment of Paediatrics and Child Health, University of Natal, Durban,2.3 year mean duration of dialysis 78 6 6 months). Frequency of
South Africa. Focal segmental glomerulosclerosis (FSGS) is the mosthypotension was 3.6%. By another way frequency of hypertension in
common form of steroid-resistant nephrotic syndrome in children andthe whole populations of CHD of Charles Nicolle’s Hospital (n 5 133)
is increasing in incidence throughout the world. It is the second com-decreases when duration of hemodialysis is prolonged (73.8% of the
monest cause of progression to end stage renal disease and is one ofpatients were hypertensives when duration of hemodialysis was below
the most difficult management problems in both paediatric and adult5 years VS 15.3% when duration of hemodialysis was above 10 years).
nephrology units. Seven children with steroid resistant (SR-FSGS) wereDuring VM heart rate falls in 35% of HOT and in 58% of NT. NA
placed on a therapeutic protocol of methyl prednisone (MP), oral predni-levels were nearly similar in HOT and NT (224.29 6 24.10 pg/ml VS
sone (MP), oral prednisone given over 18 months and oral cyclophos-211.85 6 20.21 pg/ml). Al through PRA was higher in CHD than in
phamide (CYC) given for eight to twelve weeks (Regimen A). Anothernormal population, it was identical in the two groups of patients (HDT 5
five children with SR FSGS were treated with a shorter course of MP7.02 6 1.28 pg/ml/h, NT: 6.95 6 1.57 pg/ml/h, normal population: 0.2
(3 consecutive daily doses) intravenous CYC (monthly doses over 6to 0.28 pg/ml/h. Similar data were observed with PAC (HOT 5 817.5 6
months) and oral prednisone 2 mg/kg (alternate days) (Regimen B).105.2 pg/ml. NT 5 630.3 6 123.8 pg/ml. normal population: 10 to 150
In Regimen A, one child had a short remission, in the remainingpg/ml) We conclude that with increasing duration of dialysis treatment
six, oedema subsided, the urine protein/creatinine ratio decreased,(i) baro receptors dysfunction occurs (ii) there is a resistance to the
haematuria disappeared and the glomerular filtration rate (GFR) in-effect of vaso-constrictive hormones. This might be one important cause
creased. The observation period was 21–42 months and the drugsof arterial hypotension in patients on long hemodialysis treatment.
were well tolerated. In Regimen B, two patients went into complete
remission, one had partial remission. In these children, oedema cleared;
the urine protein/creatinine ratio decreased; haematuria disappearedLithogenic factors in black controls and black and white recurrent
stone formers. N.A. Whalley, M. Martins, M.I. Sonnekus and A. M. and the GFR rose. The follow-up was between 3–34 months. Minor
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side effects were alopecia and transient hypertension. Of concern were susceptibility of American B to develop H and its target organ compli-
cations are not well understood. It has been proposed that, in B, lowersevere infections in 2 children; one of whom died. Compared to Regi-
men A, Regimen B is six times cheaper with quarter the number educational level and reduced access to medical care my contribute
to the development of these target organ complications. In Tunisia,of hospital visits. These observations may be of value in designing
appropriate multicentre controlled trials, for the rational and optimum when socio-cultural and economic factors contributing to H do exist,
no correlation with ethnical origin is found. We have prospectivelymanagement of SR-FSGS.
investigated two groups of hypertensive adult patients, G1: 100 B pts
(50 M 1 50 W) and G2: 100 white pts (50 M 1 50 W). This two groups
were matched regarding social and geographical origin, educationalNephrotic syndrome in South African children revisited: Changing
perspectives over 20 years (1976–1995). Bhimma R., Coovadia H.M., level, occupation, physical activity, matrimonial and genital activity
for women, tobacco and alcohol habits, medication and family historyand Adhikari M., Department of Paediatrics and Child Health, Univer-
sity of Natal, Durban, South Africa. More than a quarter century ago, of diabetes mellitus and H. Our results read as follow:
many centres in Africa had begun to identify unusual features of the
Nephrotic Syndrome (NS) on this continent. We review our 20 year White Black P
experience of 636 children with 23 (4%) were Coloureds (mixed race),
Age (yr) 51611 50612 NS91 (14%) could not be categorised and were excluded from the analysis.
Obesity (BMI . 25) 65% 78% ,0.05Minimal change nephrotic syndrome (MCNS) continues to show the
Anti-HT treatmenttypical pattern among Indians: however it remains uncommon in
Monotherapy 61% 47% ,0.05Blacks. 134 of 168 (80%) Indians had biopsy-proven MCNS and 94%
Bitherapy 38% 41% NSof these were steroid sensitive (SS); 60 of 65 (92%) had SSNS but
Tritherapy 1% 12% ,0.01without renal biopsy. Only 14% of Blacks had either biopsy-proven
Complicationstypical MCNS or SSNS without biopsy: a further 32 of 307 (10.4%)
Coronary disease 2% 11% ,0.001had MCNS lesions on biopsy but were steroid resistant (SR). The
Left VH 4% 11% ,0.02prevalence of focal segmental glomerulosclerosis (FSGS) appears to
Pl Cr (mmol /l ) 79 630 115668 ,0.03be increasing. Among Indians 443% had FSGS in 1995 compared to
Cr Cl (ml/mn) 110 640 88642 ,0.0012% in 1976. 28% of Blacks and 44% of Coloureds in 1995 had FSGS
U Pr (g/24 h) 0.1760.1 0.5360.15 ,0.001compared to 5% Blacks in 1970 (we had no Coloureds then). Only
Stroke 1% 7% ,0.0014% of these patients were SS; none of whom were Blacks. Membranous
Retinopathy II/III 0/2% 4/28% ,0.001nephropathy is the commonest type of lesion seen in Blacks accounting
Blood pressure controlfor 40%; 86% were associated with hepatitis B antigens. 7 of 286 (2.4%)
Well 49% 9% ,0.001Indians and 6 of 23 (26%) Coloureds had idiopathic membranous
Mild 49% 65% ,0.001nephropathy; 15% were SS. Proliferative lesions were uncommon in
Uncontrolled 2% 26% ,0.001all population groups, present in 6% of Blacks; 5% Indians and 9%
Coloureds in 1995 compared to 33% Blacks and 15% Indians in 1970.
Overall mortality was 3%. In brief, this is the largest reported series Our study shows that in the absence of difference in socio-cultural
and economic factors, H in B seems to be more severe with frequentof NS among children in Africa and shows a typical pattern in Indians,
and unusual frequency of histological types in Blacks and an intermedi- target organ complications than in white. The role of genetic rather
than socio-economic factors is likely to be implicated.ate picture in Coloureds.
Insulin resistance in a group of hypertensive Cameroonians. Youmbissi End-stage renal disease of the Tunisian child: Epidemiology and etiolo-
gies. A. Kamoun*, F. Jawahdom*, T. Ben Abdallah**, F. Ben Moussa**,T.J., Mbanya J.C., Tokpanou E., Departments of Nephrology and Endo-
crinology Medical School, Yaounde, Cameroon. Insulin resistance and J. Hachicha***, H. Ben Maiz**, R. Lakhoua*, Department of Pediatrics,
Charles Nicolle’s Hospital, Tunis. Department of Nephrology, CharlesHyperinsulinaemia were studied in 17 non obese newly diagnoses Cam-
eroonian Hypertensives with normal glucose tolerance and an equal Nicolle’s Hospital, Tunis. Department of Nephrology, Hedi Chaker’s
Hospital, Tunis, Tunisia. Data on the epidemiology and etiologies ofnumber of matched normal glucose tolerant normotensives. Both
groups showed normal and comparable a) mean fasting serum insulin pediatric renal failure in northern Africa are scarce and basically con-
cern subjects who have not reached end-stage renal disease (ESRD).levels (5.9 versus 4.6 micro IU/ml) b) mean fasting glucose/insulin
ratios (0.67 versus 0.78) c) mean basal serum C peptide levels (0.67 The aim of the present study was to establish the incidence, the charac-
teristics and the etiologies of ESRD among Tunisian patients underversus 0.78 ng/ml) d) mean stimulated serum C peptide levels (4.40
versus 4.05 ng/dl) e) mean fasting Insulin/C peptide ratios (3.4 versus 15 years. Patients and methods: Our study includes 134 Tunisian chil-
dren with ESRD admitted for taking in change by dialysis. Sixteen5.6) Both groups showed no significant variation in the insulin areas
under curve (144 versus 146) after ingestion of glucose, the mean children were less than 5 years and 43 were aged between 5 and 10
years. The sex ratio (M/F) of the children was 1.91. Results: TheGlucose/Insulin ratio followed almost the same curve in both groups.
No correlation was found in hypertensives between a) Fasting blood estimated incidence of pediatric ESRD in Tunisia is 7 new cases per
year and per million child population under 15 years. The chief etiolo-glucose and systolic blood pressure (SBP) (R 5 0.28), diastolic blood
pressure (DBP) (R 5 0.29) or mean blood pressure (MBP) (R 5 0.31) gies of ESRD are glomerulonephritis (19%), hereditary nephropathies
(29%), malformative uropathies (16.5%), renal hypoplasia (4.5%) andb) Fasting serum insulin and SBP (R 5 0.29). DBP (R 5 0.31) c)
Fasting Glucose/Insulin and SBP (R 5 0.20) DBP (R 5 0.14) or MBP amyloidosis (4.5%). The etiology of ESRD was undetermined in 26%
of cases. Primary hyperoxaluria (18 cases) represent the most important(R 5 0.22). Hypertensives, had higher serum cholesterol (P 5 0.01)
lower HDL cholesterol (P , 0.01) but similar serum Triglycerides etiologal group among hereditary nephropathies. Conclusion: Our
findings, compared with the European data, show a particularly highand apolipoprotein A-1 as normotensives. Our study did not confirm
Ferrannini’s hypothesis that essential Hypertension could be an insulin frequency of primary hyperoxaluria (13%) and an unusual proportion
of male subjects.resistant state independent of obesity or non insulin dependent diabetes
mellitus. It showed however the usual association between Hyperten-
sion and altered serum lipid levels.
The problem of end stage renal failure in the indigenous populations
of Australasia. D.J. Pugsley, A.E. Seymour, W. Hoy, Renal Unit, The
Queen Elizabeth Hospital, Woodville, South Australia 5011. AustralianHypertension in Tunisian black population. M. Ben Hmida, G. Brillet*,
M. Chtara, J. Hachicha, K. Charfeddine, A. Jarraya, Dpt. of Nephrology, Aborigines (AA) and the Maori and Pacific Islander (MPI) population
of New Zealand (NZ) are known to harbour rates of serious renalH Chaker Hosp. Sfax Tunisia & *Necker Hosp., Paris, France. Ac-
cording to US data, the prevalence of hypertension (H) is greater in disease that are much higher than those found in other residents of
Australia and NZ. Between the ages of 20 and 50, the entrance of AAblack (B) adults than in white. The reasons for the apparent increased
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onto end stage renal failure (ESRF) programmes is at least 10 times Pe´diatrie, Hoˆpital Charles Nicolle, Tunis; **Laboratoire de Biochimie,
that of other Australians. MPI constitute half of all patients entering Hoˆpital Charles Nicolle, Tunis; ***Laboratoire de Biochimie et INSERM
ESRF programmes in NZ, although they only comprise 13% of the U 90, Hoˆpital Necker, Paris. We report on 31 children (16 boys) pre-
population. The prevalence of non-insulin dependent diabetes mellitus senting with type 1 primary hyperoxaluria (PH1). The mean age at
(NIDDM) is high in these populations and diabetic nephropathy is a diagnosis was 6.1 years (range: 3 months–14.8 years) and the average
major contributor to the burden of ESRF. The control of hypertension follow-up period was 25 months. The mean delay between first symp-
and hyperglycaemia is difficult to achieve, and the rate of progression tom and diagnosis was 1.3 year. The diagnosis of PH1 was carried out
of renal failure is often rapid. Among the causes of glomerulopathy by determination of oxaluix in 16 cases, by renal histology in 11 cases
(G) in AA there is a striking incidence of glomerulomegaly which and by physical analysis of urolithiasis in 9 cases. In the 9 cases where
progresses to ESRF by way of increased glomerulosclerosis. Mesangio- urinary glycolate was assayed, the level was found high. At the time
pathic G is differently distributed and mesangio-capillary GN is over of diagnosis the renal function was normal in 10 children, moderately
represented when compared with the non-Aboriginal population. altered in 1 and severely so in 20. During the follow-up the renal
Membranous G has rarely been reported. Preliminary research sug- function remained stable in 10, greatly improved in 2, deteriorated in
gests that: renal disease later in life may be associated with obesity 5. The 14 patients who experiences end-stage renal disease at the
developing against a background both of low birth weight and repeated diagnosis remained unchanged. Urinary stones were present in 23
infections. How this may be linked to the observed pattern of pathology patients among 24 aged more than 2 years and in one among 7 infants. A
is not yet known. The treatment of ESRF by dialysis and transplanta- response to pyridoxin therapy was noticed in 2 patients. Extracorporeal
tion is difficult for cultural, social, geographic and economic reasons, shock wave lithotripsy performed in 7 patients was efficient in only 3.and the survival of AA is significantly worse than that found amongst
In 9 patients oxalate bone disease was correlated with both renalother Australians with ESRF.
function and dialysis duration, whereas retinal involvement observed
in 7 patients was not.
Acute renal failure for children (74 cases). Fatihi E., Hachim K., Beng-
hanem Gharbi M., Zahiri K., Ramdani B., Zaı¨d D., Service de ne´phrolo-
Karyomegaly of tubular cells as early stage marker of the nephrotoxic-gie-he´modialyse, CHU Ibn Rochd, Casablanca, Morocco. A retrospec-
ity induced by Ochratoxin A in rats. Achour A.*, Maaroufi K.**, Zak-tive study of 74 files of acute renal failure (ARF) of the child collected
hama A.*, Bouraoui S.*, Elmay M.*, Bacha H.**, *Service de Ne´phrolo-from 1990 to 1996 in the department of Nephrology-Hemodialysis of
gie CHU Monastir—TUNISIE; **Laboratoire Toxicologie—F.M. deU.H.C. Ibn Rochd in Casablanca permitted to analyse the etiologic
Monastir—TUNISIE. Cases of Karyomegaly were described by Sclareand prognostic factors of this affection. If the positive diagnosis doesn’t
and by Mihatch in patients affected with tubular-interstitial nephropa-make problems, the determination of the causes and the physiopatho-
thy. The Karyomegalic cells showed enlarged nuclei with accumulationlogic mechanism is difficult. The etiologies of the ARF of the child
of genetic material. No aetiology was suggested. Our study in ratswere dominated by the glomerular nephropathies (60.8%) which the
acute post-infections glomerulonephritis represent the majority experimentally intocicated by ochratoxin A, a well-known nephrotoxic
(40.5%) followed by hemolytic and uremic syndromes. The factors of compound, indicates the presence of Karyomegaly with alteration of
poor prognosis were represented by etiologic circumstances (Obstruc- the tubular tissue. In control animals no karyomegalic cell was detected.
tion), the etiopathogenic factors (the infection), the young age of the These observations suggest that karyomegaly with megacytosis may
child (newborn and baby), the oligoanuria, the existence of complica- be caused by the nephrotoxic ochratoxin A in the kidney. In addition
tions with septicemic type, the digestive hemorrhage, the severe neuro- abnormal mitosis together with karyomegalic cells were observed at
logic disturbances, the pneumopathies, the important retention of salt ealier stage of the intoxication (30 days) suggesting possible regenera-
and water into the body overload or the metabolic acidosis. The preco- tion in the OTA insults are stopped. After 90 days of treatment, the
cious and frequent hemodialysis associated to symptomatic and etio- degeneration increased and only karyomegalic and apoptotic cells were
logic treatment permitted to have a rate of good results equal to 89.1%, observed indicating that the regeneration does no more occur and that
this rate in comparison with data of literature is satisfactory. The real the regeneration become irreversible.
amelioration of the prognosis can be obtained only if a preventive
action aiming at the treatment of etiopathogenic factors which can
cause the acute renal failure and a best knowledge of this pathology Congenital/infantile nephrotic syndrome with pulmonary stenosis—A
by the nephrologist. new syndrome? Kala U.K., Jacobs D.W.C., Verhaart S. and Goetsch
S., Department of Paediatrics, Chris Hani Baragwanath Hospital, Uni-
versity of the Witwatersrand. Aim: Analyse patients presenting with
Significance of microalbuminuria in Type II diabetic patients. F. El congenital/infantile nephrotic syndrome (CNS) with associated pulmo-Younsi, K. Khiari, N. Ben Abdallah, T. Ben Abdallah, H. Ben Maiz,
nary stenosis (PS) with regards to clinical features, laboratory andDepartment of Nephrology and Internal Medicine (Pr H. Ben Maiz),
histological data and natural history. Methods: Descriptive study. Re-Charles Nicolle Hospital—Tunis—Tunisia.In insulin dependent diabetes
sults: Ten patients with a mean age of presentation 11 6 9.8 months, 5(IDDM), microalbuminuria (malb) predicts renal and cardiovascular
males and females with sets of siblings, and one with a family history ofdisease. We report the result of malb determination in 50 type II
affected siblings. All patients having a degree of hyperteliorism, profusediabetic patients (21 men, 29 women) compared to 30 non diabetic
sweating, flattened nasal bridge, soft ear pinnae, hepatosplenomegaly,controls (NDC). Urinary albumin levels were measured by radioim-
bilateral nephromegaly and gross nephrosis. The mean gradient acrossmuno-turbidimetry. Mean malb concentration was less than 5 mg/l in
the pulmonary valve echocardiographically being 35 6 14.3 mm Hg,NDC versus 18.2 mgr/l in NIDDM. There was a significant increase
the higher gradient having right ventricular heave—but all havingof urinary albumin excretion (UAE) rates in NIDDM with high blood
pulmonary ejection systolic murmur. Histologically varying degree ofpressure. Correlation was also positive between malb and body mass
focal glomerulosclerosis with segmental and or global fibrosis with cystindex (BMI) and lipid abnormalities, essentially triglycerids. Correla-
formation in all except one. Associated varying intensity of interstitialtion between malb and duration of diabetes was negative. These results
fibrosis, the arterioles appearing hyperplastic. On electron microscopyshowed a positive correlation between UAE and several cardiovascular
(EM) all have thin membranes for age and Alport like changes ofrisk factors like obesity, hypertension and hyperlipidemia, malb could
lamination and rarefaction with loss of lamina densa. Two out of tenbe considered as a predictor of macrovascular complications in
went into renal failure after a mean of 22 months. Four demised twoNIDDM patients. Hyperinsulinemia is frequently present in this situa-
from gastroenteritis, two from renal failure and one of which had cerebraltion known as syndrome X.
thrombosis and the other chickenpox. Two lost to follow up. Presently
four patients alive with a follow up 21.3 6 17.8 months—all still ne-
phrotic. Conclusion: All patients presented having distinct clinical fea-Type 1 primary hyperoxaluria: Tunisian experience about 31 pediatric
tures and pathology. A variant of Alport’s or a defect in collagen orcases. Kamoun A.*, Abdelmoula J.**, Daudon M.***, Jawahdou F.*,
Zghal A.**, Ben Ammar S.**, Belkahia C.**, Lakhoua R.*, *Service de other basement membrane protein not described yet?
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Intravenous iron sucrose on haemodialysis—A multicentre clinical analysis of variance were used. 106 patients were recruited (54 women
study. R. Van Zyl-Smit, M.R. Moosa, C.D. Potgieter, H.G. Viljoen, and 52 men, mean age: 44.1 years, SD: 10.26); 8 patients were excluded.
S. Naiker, Renal Unit, Groote Schuur Hospital Dept. Medicine, Univer- Of the remaining, 33 were on CLZ, 32 on CLZ-HCTZ and 33 on
sity of Cape Town. Five South African haemo-dialysis units participated HCTZ. The dosage was doubled from week 4 in 17 patients on CLZ
in a study designed to evaluate the tolerance, safety and efficacy of (51.5%) 9 patients on CLZ-HCTZ (28.1%) and in 18 patients (54.6%)
an intravenous iron sucrose preparation (Venofert). A total of 131 on HCTZ. Response rates (DBP , 90 or a decrease of DBP from
patients were included in the safety, and 105 in the efficacy analysis. baseline . 10 mm Hg, at week 8 were the following: 24 patients (72.7%)
All patients had a haemoglobin level of #10g/dl, a serum transferrin on CLZ, 21 (65.6%) on CLZ-HCTZ and 23 (69.7%) on HCTZ. There
saturation of #20% and serum ferritin of #200 ng/ml. The drug was was no significant difference. But at week 4 responses were: 16 patients
administered during dialysis at a dose of 5 ml (100 mg), three times (48.5%) on CLZ, 23 patients (71.9%) on CLZ-HCTZ and 17 (51.5%)
per week till a pre-calculated cumulative dose was reached. It was on HCTZ. This improvement of the response rates from week 4 to
extremely well tolerated with the most frequent side effect possibly week 8 in the CLZ-HCTZ groups is due to the fact that the dosage
related to the drug being “hypotension” reported in 13% of cases. The had to be doubled in 51.5% in the CLZ and 54.5% in the CLZ and
serum ferritin rose from a mean baseline of 74 ng/ml to 486 ng/ml by 54.6% in the HCTZ groups whereas only 28.1% in the CLZ/HCTZ
week two, TIBC from 54 mmol/l to 44 mmol/l and % transferrin satura- group needed the double dose. 9 adverse events CLZ-HCTZ group
tion from 13.6% to 25.8%. The mean baseline haemoglobin was 7.3 and 2 in 2 patients (5.7%) in the HCTZ were observed. Coughing was
g/dl SD 1.6, it rose to 9.2 g/dl SD 1.8 by week two and 9.2 g/dl SD 1.9 the most frequent event (4 patients on CLZ, 1 on CLZ/HCTZ, and 0
during the observation period, the haematocrit from 22.5% to 28.3% on HCTZ). No serious adverse event could be observed. There was no
and 28.6%, the MCV from 83.1 fl to 89.6 fl and 89.9 fl, the MCHC from significant change in the clinical or laboratory variables during the study.
32.1 g/dl to 32.6 g/dl and 32.5 g/dl. Conclusions: Venofert appeared to Cilazapril alone or better in combination with hydrochlorothiazide is
be perfectly safe with none of the possible clinical side effects being an efficacious and safe treatment in Black African Hypertensives.
different from those expected during uncomplicated haemodialysis. No
adverse biochemical reactions were observed. The rise in haemoglobin
levels, haematocrit and MCV was highly significant, whilst all parame- Detection of Oxalobacter in the human gastrointestinal tract. Arvinda
ters of iron status were changed in a positive way. Sooka,1 Anthony M. Smith, Anthony M. Meyers2 and Hendrik J. Koorn-
hof, 1South African Institute for Medical Research, Johannesburg, 2Dept.
of Nephrology, Johannesburg Hospital. Anaerobic Oxalobacter species
Renal biopsies of HIV positive patients at Baragwanath Hospital 1989– have been known to metabolise oxalates in the colon of normal people.
97. L. Pantanowitz, S. Goetach, O. Butler, I.J. Katz, Baragwanath Hospi- We postulate that a deficiency of these bacteria may be responsible
tal, Dept. of Nephrology. HIV associated nephropathy (HIVAN), more for the production of oxalate kidney stones and an abundance of these
common in black patients, simultaneously affects glomeruli, tubules bacteria may protect Black South Africans from oxalate calculi. The
and interstium. The nephropathy is characterized histologically by focal aim of the study was to detect Oxalobacter organisms in stools of black
segmental sclerosis and hyalinosis (FSH) and tubulointerstitial nephri- males. The anaerobic technique used to culture the bacteria was similar
tis (TIN). The aim of this study was to retrospectively characterize to that described by Hungate using a roll tube method selecting for
HIVAN seen at Baragwanath hospital and determine a possible im- oxalate-metabolizing bacteria. Since Oxalobacter is difficult to culture,
mune-mediated aetiology. Renal biopsies of 21 black HIV positive we designed a PCR technique to detect Oxalobacter OXIT gene frompatients (mean age 29 years, 71% female) from 1989 to 1997 were stool specimens. The Oxalobacter was cultured in an anaerobic brothreviewed. Histopathological findings in all cases revealed concomitant for broth for 48 hours. The cells were harvested and used in a 50 mlglomerular and tubulointerstitial pathology. Glomerular disease was
PCR reaction to amplify a ≈795 bp DNA fragment using appropriatepredominated by FSH (62%). Mesangial proliferative, membranous,
PCR primers. To determine the specificity of the PCR, we analyzedand post infectious GN each accounted for 14% of histopathology.
DNA from eleven bacterial species commonly present in faeces. NoMembrano-proliferative GN was found in 5%. Eighty one percent of
products were amplified in these control organisms giving a 100%biopsies showed TIN. Acute tubular necrosis was present in 48% of
primer specificity. A commercial kit was used to extract DNA frombiopsies and pyelonephritis in 14%. Renal tuberculosis was found in
stool specimen which were seeded with Oxalobacter. PCR successfullyone case. Immunflouesence revealed IgM (31%) and IgG (19%) posi-
demonstrated Oxalobacter in these spiked specimens. By estimatingtive in capillary tufts, deposition of IgA (38%) and albumin (25%) in
the PCR product, a semi-quantitative method will be devised to mea-tubular casts and cells, and C3 (44%) in the mesangium and sclerotic
sure the quantity of Oxalobacter in various population groups andareas. Glomerular deposits were seen with regularity using TEM. En-
stone formers.dothelial tubuloreticular inclusions were found in two cases. These
results are consistent with previous reports of a ‘pan kidney’ pathologi-
cal involvement in HIVAN. They confirm the frequency of FSH and
Mitochondrial cytopathy in Fanconi syndrome. R.D. Gilbert, M. Emms,TIN in these patients. Infectious complications are uncommon. Histo-
C. Sinclair-Smith, M. Shuttleworth, Red Cross War Memorial Children’spathological findings suggestive of an immune-mediated aetiology war-
Hospital, Private Bag Rondebosch 7701. Mitochondrial abnormalitiesrant further study in South Africa.
are now recognised as a cause of Fanconi syndrome. We describe 2
children, 1 with Pearson’s syndrome, with Fanconi syndrome and bi-
zarre mitochondria in the renal tubular cells. A 21-month-old boy wasEfficacy and safety of Cilazapril (CLZ) versus hydrochlorothiazide
referred because of fever and dehydration. He was underweight, pale(HCTZ) and a combination of Cilazapril/Hydrochlorothiazide (CLZ/
and had a 2 cm firm hepatomegaly. Both kidneys were massively en-HCTZ) in a group of black Africans with mild to moderate hypertension.
larged. There was laboratory evidence of generalised proximal tubuleYoumbissi T.J., Department of Nephrology Medical School, Yaounde,
dysfunction, elevation of blood lactate and pyruvate and mild macro-Cameroon. The aim of this study was to find out whether CLZ alone
cytic anaemia. The bone marrow showed dyserythropoeisis with vacuo-or in combination was an efficacious and safe treatment in black African
lated granulocyte precursors. Renal and muscle biopsies showed highlyhypertensives. This was a double blind, multicenter randomised three
abnormal mitochondria. He died shortly afterwards of uncontrollablearm parallel group study with a 2 week single blind placebo run-in
metabolic acidosis. Necropsy confirmed pancreatic atrophy. A 10-year-period to the 8 week double blind treatment. Test drug dosage was
old girl was referred because of poor response to treatment of Fanconi2.5 mg for CLZ, 12.5 mg for HCTZ and CLZ 2.5 mg/HCTZ 12.5 mg
syndrome diagnosed at 7 years; no cause had been found. She had severefor the combination. Patients previously treated with symptomatic
rickets, muscle wasting and weakness. Investigations confirmed Fanconidrugs underwent a 4 week wash-out period. After the screening at
syndrome with elevated lactate and pyruvate. Renal and muscle biop-week 22, patients began a 2 week placebo run-in and selection period.
sies showed abnormal mitochondria. She has improved on more aggres-Patients with a sitting DBP of .95 mm Hg, and ,155 mm Hg at week 0
sive management. Mitochondrial abnormalities need to be consideredentered the active treatment period. If the sitting DBP was .90 mm
in the differential diagnosis of Fanconi syndrome. Renal biopsy withHg, at 4 week, the medication was doubled. Clinical and laboratory
evaluations were performed at weeks –2, –1, 0, 4 and 8. x2 test and electron microscopy may be indicated in some patients.
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Acute renal failure in children in the Congo. Assambo-Kieli C., As- of chronic renal failure advanced age (70%), heart failure (11%).
Aggressive diuretic therapy (11%), diabetes (11%), and associationsounga A.G., Mafoua A., Nzingoula S., Brazzaville’s University Hospi-
tal and Marien Ngouabi University, Brazzaville, Congo. Acute renal of more than 2 factors was noted in 70% of our patients. Mean durations
of NSAID therapies were 32.5 days fordiclofenac and 47.9 days forfailure (ARF) is a common pathology in the Congo. This is a 6 year
retrospective study aiming at analyzing the epidemiology and treatment indomethacine. Acute renal failure was severe in 5 patients (29%) and
necessitate a temporary hemodialysis sessions in 2 patients (11.9%).modalities of ARF in Brazzaville’s University Hospital from 1989 thru
1994. One hundred and five cases of ARF including 54 boys (51.4%) Proteinuria was positive in 11 cases (61%) (Mean 2.18 g 1 1.1/day). In
15 patients ARF greatly improve when NSAID was stopped, although 2and 51 girls (48.6%) have been recorded out of 10,512 children admitted
in the Pediatrics Department (0.99%). ARF represents 13.09% of 802 patients with CRF were placed in HD programm.
kidney patients. The main etiologies of ARF include: acute gastroenter-
itis with dehydration (25.7%), nephrotic syndrome (17.4%), sepsis
(15.23%), malaria (12.38%) and acute glomerulonephritis (9.5%). Allograft membranous nephropathy: Favourable response to high dose
steroids. A.A. Khad, P Johnston, D.M. Lewis, A.M. Davison, Depart-Most cases were treated with conservative measures while peritoneal
dialysis (PD) was used in 8 cases (7.62%). The outcome of ARF was: ment of Renal Medicine St James’s University Hospital, Leeds, UK.
Recurrent membranous nephropathy in renal allografts is infrequent.recovery in 50.4% lethality in 37.14% and chronic renal failure was
found in 9.52% of cases. The high lethality rate and the high cost of Twelve cases were reported before 1982 and a further 21 between
1982 and 1995. De novo membranous nephropathy is more common,PD render urgent the need for preventive measures.
with an incidence of 1–2%. The principle manifestation is proteinuria
and progressive loss of graft function. Intensification of immunosup-
pressive regimes has had little impact on graft survival. We reportThe clinico-pathological manifestations of renal disease in HIV positive
patients, Tygerberg Hospital. A.A. Walele, W.D. Bates and M.R. 4 patients, with nephrotic range proteinuria secondary to allograft
membranous nephropathy, in whom remission followed high dose ste-Moosa, University of Stellenbosch, Cape. Three characteristic patterns
of HIV related renal disease HIV-associated nephropathy (HIVAN), roid therapy. The first patient was a 43-year-old man transplanted in
1990 (original disease small kidney: ? familial glomerulonephritis).immune-complex glomerulonephritis (IGGN) and tubulo-interstitial
nephritis (TIN) are reported. The aim of the study was to document Immunosuppression included Prednisolone, Axathinoprine and Cyclo-
sporin and good graft function was achieved. Cyclosporin was stoppedthe clinical manifestations of renal disease in HIV positive patients
who underwent renal biopsy at Tygerberg Hospital. Since 1990 nine after 16 months. Three months later the patient developed proteinuria
(.11 g/day). Serum creatinine remained normal. An allograft biopsyrenal biopsies in eight HIV positive patients, mean age 29 years, have
been undertaken. Only one patient had AIDS defining criteria. Four revealed membranous nephropathy. The patient was treated with 3
boluses of intravenous Methylprednisolone (0.5 g) and then oral Pred-patients with histological features characteristic of HIVAN had ne-
phrotic syndrome and renal failure (Cr . 120 mmol/L) was present nisolone, 125 mg alternate days for four months. Proteinuria dropped
to 0.5 g/day, and serum creatinine remained normal. The second patientin three of them. Another three patients with ICGN presented with
nephritic/nephrotic syndrome, low complements and renal failure. was a 51-year-old women patient transplanted in 1989 (original disease
bilateral small kidneys). Normal graft function was achieved on Cy-Biopsy showed TIN in one patient with renal failure. Two patients
were dialysis dependent. Histology confirmed HIVAN in one and closporin monotherapy. After 6 months she was converted to Predniso-
lone and Azathioprine. Twelve months later she developed proteinuriaICGN in the other who progressed to crescentic glomerulonephritis
on follow-up renal biopsy. This small renal biopsy series in HIV positive (12 g/day). Allograft biopsy revealed membranous glomerulonephritis.
The patient was treated with 3 boluses of intravenous Methylpredniso-patients documents three histopathological patterns. A typical clinical
presentation was nephritic/nephrotic syndrome with renal failure. lone (1 g), and 125 mg Prednisolone alternate days for four months.
Proteinuria dropped to ,0.5 g/day and serum creatinine remained
normal throughout. The third patient was a 52-year-old man trans-
planted in 1988 (original disease chronic glomerulonephritis). Immuno-Antimicrobial acute renal failure (ARF). Ben Dhia N., Chaabouni M.,
Bouraoui S., Frih A., Mahjoub S., Elmay M., Nephrology Dep. CHU suppression included Prednisolone, Azathioprine and Cyclosporin and
normal graft function was achieved. Cyclosporin was withdrawn afterMonastir 5000—Tunisia. The most serious clinical manifestation of
antimicrobial nephrotoxicity is the occurence of ARF. It’s difficult to 24 months. Thirty months post-transplant, the patient developed 4.5
g/day of proteinuria. Serum creatinine remained normal. Allograftlink ARF to a particular antibiotic other causes usually exist and
contribute to renal damage. Authors report a retrospective study of biopsy revealed membranous nephropathy. The patient was treated
with 3 boluses of intravenous Methylprednisolone (1 g) and oral Predni-26 patients where ARF was due to gentamicine 18 cases, penicilline
4 cases, oxacilline 1 case, colimycine 1 case, Rifampicine 1 case and solone, 125 mg alternate days for two months. Proteinuria declined
rapidly to 0.5 g/day. The fourth patient was a 29-year-old man trans-vancomycin 1 case. Ages varied from 15–83 years (Mean 50.8), sex
ratio: 1. Serum creatinine was in normal ranges before antimicrobial planted in 1990 (original disease focal proliferative glomerulonephri-
tis). Normal graft function was achieved on cyclosporin monotherapy.treatment in 92%, 75% of our patients were nonoliguric. ARF was
mild to moderate in 19 cases (73%) and severe in 7, hemodialysis After 14 months he was converted to Prednisolone and Azathioprine.
One month later the patient developed proteinuria (7 g/day). Allograftsessions were indicated in 2 patients and renal biopsies in 2 cases.
Imputability of ARF to antimicrobial agents was established on clinical biopsy revealed membranous nephropathy. The patient was treated
with 3 boluses of intravenous Methylprednisoline (1 g) and 125 mgcriterions: Frank increase of serum creatinine after initiation of the
drug, coexistence of allergic signs, or risk factors of nephrotoxicity. Prednisolone alternate days for five months. Proteinuria declined to
1 g/day and serum creatinine remained normal throughout. ContraryWe conclude that critically ill patients, who often have a marginal
renal blood flow and/or additional factors predisposing to antibiotic to previous reports, we found high dose steroids to be effective in
suppressing nephrotic range proteinuria in allograft membranous ne-nephrotoxicity must be monitered.
phropathy.
Nephrotoxicity of non steroidal anti-inflammatory drugs (NSAID).
Ben Dhia N., Chaabouni M., Frih A., Bouraoui S., Touzi M., Bergaoui Analysis and value of angiography in live related renal transplantation.
A.A. Haffejee, K.S. Satyapal, B. Singh, L. Ramsaroop and S. Naicker,N., Elmay M., Nephrology Department—CHU Monastir 5000—
Tunisia. There are several reports on nephrotoxicity of NSAID. They Department of Surgery and Medicine, University of Natal. Introduction:
In diagnostic work-up of renal patients, it is necessary to be familiaract mainly by reducing the production of prostaglandins and thrombox-
ane, which are vasodilatators particularly important in renal hypoperfu- with blood supply of kidneys and number of arteries supplying each
kidney. Renal angiography remains gold standard in pre-operativesion situations (hypovolemia, cardiac failure . . .). In 10 years (1986–
1996) 17 patients presented to our unit in renal failure associated with investigation. Study aimed to evaluate accuracy of pre-operative angi-
ography reporting compared to intra-operative findings. Patients andthe use of NSAID. Ages varied from 26–76 years (Mean 55.3). A
skin rash was reported in 4 cases suggesting allergic basis. 14 patients Methods: Retrospective analysis of 61 angiograms of live related do-
nors performed at Addington Hospital was compared to intra-opera-(82.5%), were oliguric and 3 anuric. Predisposing factors such as history
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tive findings of donor and recipient between 1993–1996. Age Range: and other forms of vascular access are required. Both biological and
synthetic grafts are available. The expanded polytetrafluorethylene (e-22–53 years; Sex: 26 males, 35 females; Race: 33 Indians, 16 Africans,
7 Whites, 5 “Coloureds”; Relationship: siblings: 33; parent-child: 15; PTFE) is currently the most popular alternative. Between 1993 and
1997, 10 patients underwent formation of thigh vascular access byhusband-wife: 9; relatives: 4. Angiography performed using Seldinger
technique with femoral artery puncture. PA and lateral films taken. insertion of PTFE graft between profunda femoris artery and saphe-
nous vein. These were 4 males, and 6 females, mean age 39.7 yrs (rangeReporting performed by radiologists with varied experience. Surgery
performed by team of surgeons. Intra-operative findings correlated 27–55 yrs) and mean duration of renal failure 8.5 years (range 5–15
yrs). All patients had multiple previous vascular accesses and werewith radiological reports. Results: Additional arteries encountered in
15 patients [2: 12 patients; 3: 3 patients]. Six radiological reports did assessed pre-operatively for evidence of peripheral vascular disease.
Immediate success rate was 100% and all grafts were still patent afternot correlate with operative findings (4 reported single arteries: 2
present; 2 reported dual arteries, 3 present). Anastomotic time (min- 6 months follow-up (range 1–18 months). In conclusion formation of
vascular access by insertion of PTFE graft between profunda femorisutes): one artery: 19; two arteries: 26; three arteries: 36. Post-operative
course of patients with multiple arteries was not associated with in- artery and saphenous vein is an effective form of vascular access and
merits consideration when primary forms have failed or not available.creased morbidity. Conclusion: Incidence of multiple renal arteries is
relatively high. Clinical use of kidneys with up to three arteries is not
associated with increased morbidity. Accuracy of reporting of angiogra-
phy is 91%. Glomerulonephritis pattern in Sudan. Is it changing? Suleiman S.M.,
Mukhtar B.I., Department of Medicine, U of K. In this study, the renal
biopsies done in between Jan. 1993—May 1997 were reviewed and
classified according to age & histological pattern. Out of 350 biopsiesThe kallikrein-kinin system in renal disease. Naicker S., Ramsaroop
R., Moodley D., Naidoo S., Bhoola K.D., Dept. of Med., Pathology results of 313 cases were found, 90 biopsies were from children below
16 yrs of age. It was found that the most common type is mesangiocapil-and Pharmacology, University of Natal Med. School, Durban, S. Africa.
The renal kallikrein-kinin system is involved in inflammation, blood lary type in 81 biopsies, minimal change in 56, membranous and focal
segmental in 40 each. These pattern is completely different from thatpressure regulation and sodium and water homeostasis. Tissue kalli-
krein (TK) status was studied in 16 patients with renal disease and 12 seen in previous studies from the country.
normal subjects: urinary TK activity was measured by an amidolytic
method, TK and kinin B2 and B1 receptors localised in renal tissue.
Urinary TK excretion was significantly decreased in all patients with Clinico pathological correlations in a group of African patients with
membranous glomerulonephritis (MGN). Youmbissi T.J., Mbakop A.,renal disease and more markedly so in severe renal failure. Reduction
of immunolabelled TK was noted in the distal nephron in renal disease. Eloundou D., Departments of Nephrology and Pathology, Medical
School, Yaounde, Cameroon. Forty five Cameroonian patients in WestReceptor status in normal kidney showed B2 reactivity in the entire
nephron, whereas no expression of B1 was seen. In renal disease there Africa, diagnosed as having MGN were studied and followed up over
a five year period. The mean age of these patients was 32.2 yearswas an upregulation of B1 and a downregulation of B2 receptors.
These observations indicate a probable role for the kallikrein kinin with a female to male ratio of 5/4. Proteinuria (39%) and nephrotic
syndrome (87%) were the two commonest clinical manifestations atsystem in renal disease and may contribute to its manifestations such
as hypertension. the time of diagnosis. Seventeen cases (38%) were considered idio-
pathic while the rest was associated with known aetiological factors.
Histologically the majority of the patients were either at stage I (35.5%)Urinary TK ng/lg protein
or stage II (37.8%) of the W.H.O. classification. Most patients in stage
Renal disease II and all the patient in stages III and IV showed associated important
tubular, interstitial and vascular lesions. Immunofluorescence showedControl Severe Mild
deposits to be mainly IgG (80%) and C3 (71%) while electron micros-
n 12 8 8 copy showed varied dense deposits in all cases. 17 patients with idio-
x6sem 78.9631.7 1.860.7 16.666.7 pathic MGN and 10 with Hepatitis B antigen associated MGN were
P ,0.01 ,0.05 followed up over 5 years. During this time 8 patients (30%) recovered
completely, 11 patients (40%) improved their renal function, their
degree of proteinuria and 8 others (30%) either were commenced on
dialysis or died during the same period. All these 27 patients had
undergone a 4 months period of oral steroid treatment.Localisation of tissue kallikrein in the kidney of black African women
with early onset pre-eclampsia—A pilot study. T. Naicker, S.M.
Khedun, J. Moodley, K.D. Bhoola, EM Unit, Department of Pharmacol-
Community based CAPD program at Soweto primary health careogy and MRC Pregnancy Hypertension Research Unit, Natal Medical
clinics. Sefianou L., Milkov V., Butler O., Katz I.J., Baragwanath Hospi-School, Durban. Increased renal production of vasodilator mediators
tal, Dept. of Nephrology. Health care in our country is a scarcelylike kinin would counteract the vasospasm of pre-eclampsia. This study
achievable goal with the distribution of resources as they are. IPD hasexamines the cellular localisation of tissue kallikrein (TK), a potent
failed (no employment, no rehabilitation, high infection and mortality).kinin forming enzyme within the nephron of patients with early onset
However, CAPD is successful. CAPD is attractive as it is less central-pre-eclampsia. Using the peroxidase-antiperoxidase immunoenzyme
ised and allows greater flexibility. It is now the main focus of thecomplex, TK was immunolocalised in the principal cells of the distal
Baragwanath renal programme and together with the help of primaryconnecting tubules and cortical collecting duct cells of the distal neph-
health care clinics in the township we started a modified CAPD pro-ron of the control tissue. Moderate reactivity was observed in the
gram in 1990 with 2 patients. CAPD trained nursing sisters from theepithelial lining the Bowman’s capsule. In early onset pre-eclampsia,
2 primary health care clinics serve to support this community basedTK was additionally localised in the proximal tubule cells. In patients
programme (CBP). Patients accepted for CAPD (by social worker,with hypertension in pregnancy, the occurrence of TK in the proximal
renal physician, renal nursing sister) have their Tenckoff catheter in-tubule suggests either gene induction or emiocytosis.
serted at the hospital. On discharge they report to the primary health
care clinic nearest to their homes for CAPD training. Dianeal solutions
are delivered directly to the clinics and patients collect them. SomeProfunda femoris artery to saphenous vein PTFE vascular access in
patients on long term haemodialysis. Mirza K., Pontin A., Kahn D., of the patients don’t have running water or electricity therefore the
technique was modified e.g. number and timing of exchanges, handDepartment of Surgery, University of Cape Town Medical School, Ob-
servatory 7925, Cape Town, South Africa. Arteriovenous fistula, intro- washing, treatment of peritonitis and follow up visits. The programme
now comprises of 58 patients. Against the background of mass poverty,duced by Brescia and colleagues has become the primary form of
vascular access for long term haemodiaysis. However in approximately low socio-economic growth, massive unemployment. A CBP is a very
attractive choice of dialysis for Africa. Future aims are to assess the10% of patients this is either not possible or has already been exhausted
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programme using peritonitis rate, quality of dialysis and success of in 26.31% of the cases. Biologically, 47 of our patients had normal
transaminases. The puncture biopsy of the liver achieved in 6 patientstransplants in these patients as markers.
showed a chronical viral hepatitis in 2 patients. Even if our study
concerns only one center, it permits to mind about this affection and
must be completed in the future by a multicentric study.The re-use of the dialyzers on chronic hemodialysis. Hachim K., Zahiri
K., Benghanem, Gharbi M., Fatihi E., Ramdani B., Zaı¨d D., Service
de ne´phrologie, CHU Ibn Rochd, Casablanca, Morroco. The re-use of
the dialyzers after reprocessing is chosen recently by our unit. This Cytoskeletal proteins expression in experimental diabetic nephropathy
(DN). Chiwoneso Muchaneta-Kubara, Toru Sanai, Simon Oldroyd,process permits a control of the costs with great economic income,
Graham Thomas, Tarek Sobka, Meguid El Nahas, Sheffield Kidneyspecially in our country. Our prospective study concerned the period
Institute, Northern General Hospital Trust, Sheffield, UK. The progres-from March to July 1996 about 24 hemodialysis patients (12 men and
sion of diabetic nephropathy is associated with structural changes in12 women), their mean age is 47.62 years, 22 are jobless, let 91.67%,
the glomeruli, tubulo-interstitium and vessels. Cytoskeletal proteinsand all patients are under charge of donators. The dialyzers would
such as a-smooth muscle actin (a-SMA), vimentin (V) and desminbe re-used 6.72 times on average after reprocessing on automatized
(D) have been associated with mesangial proliferation, tubular injuryapparatus using the sodium hypochlorite in 2.4% as sterilizing and
as well as interstitial fibrosis. With that in mind, the changes in thesedesinfectant agent. The coagulation of the fibers has been the cause
proteins were investigated by immunohistochemistry, during the courseof rejection of the dialyzers in 92% of the cases. During 912 session
of experimental DN (7, 15, 30, 60, 90, & 120 days) after the injectionof dialysis achieved during the study, we did not notice any febrile
of streptozotocin (45 mg/kg) in groups of rats (n 5 6). In normalor naphylactoid reaction. The index KT/V for the re-used dialyzers
rats, a-SMA and V were confined to vascular walls and glomerulirepresented 1.40 6 0.21 without significant difference with this of the
respectively with no positive stain for D. By contrast, in diabetic rats,new dialyzers. The income is about 30 $US during the year, let 1279
a-SMA was detected in the glomeruli (3.2 6 0.6%) and interstitium$US for a patient during a year of treatment.
(2.1 6 0.4) from day 7 onward and peaked on days 14 (11.4 6 2.6%)
p , 0.001 and 30 (3.2 6 0.4%) NS, respectively. Vimentin also increased
significantly by day 14 to 52.5 6 11.9% compared with sham (23.3 6Hypertension in hemodialysis patients. Hachim K., Benghanem Gharbi
4.7%) p , 0.05, before returning to baseline on day 30. It also appearedM., Fatihi E., Zahiri K., Ramdani B., Zaı¨d D., Service de ne´phrologie,
in the peritubular capillaries, interstitial and tubular cells of diabeticCHU Ibn Rochd, Casablanca, Morroco. The study turned about 36
rat kidneys from day 7 onward. Desmin appeared in the glomerularhypertensive patients undergoing chronic hemodialysis. The hyperten-
epithelial cells of diabetic rats from day 30 onward. Insulin treatmentsion is met with frequency of 46.8%, with an average of 40 years, and
introduced on day 0 or 14 after DM, normalised blood sugar levelswith male predominance. Most of these patients are base or average
and reduced the expression of all the cytoskeletal proteins. Diabeticsocio-economic level. The glomerulonephrotis have been the most
nephropathy leads to the neoexpression of cytoskeletal proteins in thefrequent etiology of chronic renal failure (69.4%). The etiopathogenic
renal cells.of hypertension is multifactoriel: hemodynamic, hormonal and meta-
bolic. . . . In the matter of treatment, we are recour to anti-hyeprtensor
of 67% of the cases. The monotherapy was used in 44%, the bitherapy Erythrocyte NA1 transports and endothelin-1 (ET) in chronic hemodi-in 19% and the triple association in 3% of the cases. The conversing alysis (CHD) patients. Pedro L. Neves, M. Faisca, I. Bernardo, A.I.
enzyme inhibitors were largely used in 33% of the cases: in monother- Anunciada, J.A. Ferreira, E. Viegas, H. Martins, A.M. Silva, Hospital
apy (16.7%), in bitherapy (13.9%) and in tritherapy (2.8%). The evolu- Distrital de Faro. Centro de Hemodia´lise de Faro—FMC. UCEH da
tion was judged good with normalisation of the tensinal numbers in Universidade do Algarve, Algarve, Portugal. In the last years erythro-
80.6% of the cases. The complications detected are: left ventricular cyte Na1 transport abnormalities have been described in uremia. It
hypertrophy in 61.3% of the cases, coronariens insuffisancy in 22.2% has also been reported that ET plasma levels are increased in uremic
of the cases. patients (pts.). In this study we analysed some erythrocyte Na1 trans-
ports: Vmax of Na-Li Countertransport (CT), Na-K-Cl Cotransport
(CO) and Na-K Pump and the Na Leak-Kpna (Na1 concentrations
Viral C hepatitis in hemodialysis patients. Hachim K., Benghanem evaluated by atomic emission spectrophotometry), in two groups of
Gharbi M., Fatihi E., Zahiri K., Ramdani B., Zaı¨d D., Service de subjects: I—Control (n 5 18) and II—CHD pts (n 5 40). Several
ne´phrologie, CHU Ibn Rochd, Casablanca, Morroco. The objective of biological and laboratorial parameters were analysed, including the
this study is to specify this affection according to the data of literature plasma ET levels (RIA—Phoenix Pharmaceuticals). Concerning the
and after the study of 57 cases of viral hepatitis C among 160 patients erythrocyte Na1 transports G-II showed only a decreased Vmax of
who suffered fron chronic renal failure and periodically hemodialysed. the Na-K-Cl CO (269 6 17 vs 342 6 31 mmol/L cel h-1, p 5 0.029),
The prevalence is 35.6%, let 57 patients: 27 men (45.64%) and 30 reflecting probably the presence of bumetanide-like factors. The ET
women (52.36%) based on search of the specific antibodies by Elisa’s plasma levels were significantly higher of CHD pts (n 5 24) than in
method. Among these 57 patients, 40 have been confirmed by Riba’s control subjects (n 5 9) (9.25 6 1.0 vs 1.89 6 0.2 pg/100 ml, p , 0.001),
method. The mean age of the patients is 45 years. The ancienty of and we found a positive correlation in these pts, between ET plasma
the dialysis which the mean duration is 4.5 years and the number of levels and the Vmax of the Na-Li CT (r 5 0.514, p 5 0.010). It has
transfusion which the mean number is 8.5 are the main risk factor of the been found that the Na-H exchanger is stimulated by ET. Our results
disease. 56.41% of the patients developed a clinical symptomatology show that in CHD pts, the Vmax of Na-Li CT (an operating mode of
the Na-H exchanger), can be related to ET plasma levels.constitud, essentially, of asthenia, the asymptomatic form is noticed
